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1. INTRODUCTION 
IMPORTANCE OF MEDICINAL PLANTS AND HERBS 
The term “medicinal plant” include various types of plants used in herbalism 
("herbology" or "herbal medicine"). It is the use of plants for medicinal purposes, 
and the study of such uses.The word “herb” has been derived from the Latin 
word, “herba” and an old French word “herbe”. Now a days, herb refers to any part 
of the plant like fruit, seed, stem, bark, flower, leaf, stigma or a root, as well as a 
non-woody plant. Earlier, the term “herb” was only applied to non-woody plants, 
including those that come from trees and shrubs. These medicinal plants are also 
used as food, flavonoid, medicine or perfume and also in certain spiritual activities. 
 Plants have been used for medicinal purposes long before prehistoric period. 
Ancient Unani manuscripts Egyptian papyrus and Chinese writings described the 
use of herbs.  Evidence exist that Unani Hakims, Indian Vaids and European and 
Mediterranean cultures were using herbs for over 4000 years as medicine. 
Indigenous cultures such as Rome, Egypt, Iran, Africa and America used herbs in 
their healing rituals, while other developed traditional medical systems such as 
Unani, Ayurveda and Chinese Medicine in which herbal therapies were used 
systematically. 
 Traditional systems of medicine continue to be widely practised on many 
accounts. Population rise, inadequate supply of drugs, prohibitive cost of treatments, 
side effects of several synthetic drugs and development of resistance to currently 
used drugs for infectious diseases have led to increased emphasis on the use of plant 
materials as a source of medicines for a wide variety of human ailments. Among 
ancient civilisations, India has been known to be rich repository of medicinal plants. 
The forest in India is the principal repository of large number of medicinal and 
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aromatic plants, which are largely collected as raw materials for manufacture of 
drugs and perfumery products. About 8,000 herbal remedies have been codified in 
AYUSH systems in INDIA. Ayurveda, Unani, Siddha and Folk (tribal) medicines 
are the major systems of indigenous medicines. Among these systems, Ayurveda 
and Unani Medicine are most developed and widely practised in India. 
Recently, WHO (World Health Organization) estimated that 80 percent of 
people worldwide rely on herbal medicines for some aspect of their primary health 
care needs. According to WHO, around 21,000 plant species have the potential for 
being used as medicinal plants? 
 As per data available over three-quarters of the world population relies 
mainly on plants and plant extracts for their health care needs. More than 30% of the 
entire plant species, at one time or other were used for medicinal purposes. It has 
been estimated, that in developed countries such as United States, plant drugs 
constitute as much as 25% of the total drugs, while in fast developing countries such 
as India and China, the contribution is as much as 80%. Thus, the economic 
importance of medicinal plants is much more to countries such as India than to rest 
of the world. These countries provide two third of the plants used in modern system 
of medicine and the health care system of rural population depend on indigenous 
systems of medicine. Treatment with medicinal plants is considered very safe as 
there is no or minimal side effects. These remedies are in sync with nature, which is 
the biggest advantage. The golden fact is that, use of herbal treatments is 
independent of any age groups and the sexes. 
 The ancient scholars only believed that herbs are only solutions to cure a 
number of health related problems and diseases. They conducted thorough study 
about the same, experimented to arrive at accurate conclusions about the efficacy of 
different herbs that have medicinal value. Most of the drugs, thus formulated, are 
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free of side effects or reactions. This is the reason why herbal treatment is growing 
in popularity across the globe. These herbs that have medicinal quality provide 
rational means for the treatment of many internal diseases, which are otherwise 
considered difficult to cure. Medicinal plants such as Aloe, Tulsi, Neem, 
Turmeric and Ginger cure several common ailments. These are considered as home 
remedies in many parts of the country. It is known fact that lots of consumers are 
using Basil (Tulsi) for making medicines, black tea, in pooja and other activities in 
their day to day life. 
 In several parts of the world many herbs are used to honour their kings 
showing it as a symbol of luck. Now, after finding the role of herbs in medicine, lots 
of consumers started the plantation of tulsi and other medicinal plants in their home 
gardens .Medicinal plants are considered as a rich resources of ingredients which 
can be used in drug development either pharmacopoeia, non- pharmacopoeia or 
synthetic drugs. A part from that, these plants play a critical role in the development 
of human cultures around the whole world. Moreover, some plants are considered as 
important source of nutrition and as a result of that they are recommended for their 
therapeutic values. Some of these plants include ginger, green tea, walnuts, aloe, 
pepper and turmeric etc. Some plants and their derivatives are considered as 
important source for active ingredients which are used in aspirin and toothpaste etc. 
 Apart from the medicinal uses, herbs are also used in natural dye, pest 
control, food, perfume, tea and so on. In many countries different kinds of medicinal 
plants/ herbs are used to keep ants, flies, mice and flee away from homes and 
offices. Nowadays medicinal herbs are important sources for pharmaceutical 
manufacturing. 
 Recipes for the treatment of common ailments such as diarrhoea, 
constipation, hypertension, low sperm count, dysentery and weak penile erection, 
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piles, coated tongue, menstrual disorders, bronchial asthma, leucorrhoea and fevers 
are given by the traditional medicine practitioners very effectively .Over the past 
two decades, there has been a tremendous increase in the use of herbal medicine; 
however, there is still a significant lack of research data in this field. Therefore since 
1999, WHO has published three volumes of the WHO monographs on selected 
medicinal plants. 
Importance of some herbs with their medicinal values 
 Herbs such as black pepper, cinnamon, myrrh, aloe, sandalwood, ginseng, 
red clover, burdock, bayberry, and safflower are used to heal wounds, sores 
and boils. 
 Basil, Fennel, Chives, Cilantro, Apple Mint, Thyme, Golden Oregano, 
Variegated Lemon Balm, Rosemary, Variegated Sage are some important 
medicinal herbs and can be planted in kitchen garden. These herbs are easy 
to grow, look good, taste and smell amazing and many of them are magnets 
for bees and butterflies. 
 Many herbs are used as blood purifiers to alter or change a long-standing 
condition by eliminating the metabolic toxins. These are also known as 
'blood cleansers'. Certain herbs improve the immunity of the person, thereby 
reducing conditions such as fever. 
 Some herbs are also having antibiotic properties. Turmeric is useful in 
inhibiting the growth of germs, harmful microbes and bacteria. Turmeric is 
widely used as a home remedy to heal cut and wounds. 
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 To reduce fever and the production of heat caused by the condition, certain 
antipyretic herbs such as Chirayta, black pepper, sandal wood and safflower 
are recommended by traditional Indian medicine practitioners. 
 Sandalwood and Cinnamon are great astringents apart from being aromatic. 
Sandalwood is especially used in arresting the discharge of blood, mucus etc. 
 Some herbs are used to neutralize the acid produced by the stomach. Herbs 
such as marshmallow root and leaf. They serve as antacids. The healthy 
gastric acid needed for proper digestion is retained by such herbs. 
 Indian sages were known to have remedies from plants which act against 
poisons from animals and snake bites. 
 Herbs like Cardamom and Coriander are renowned for their appetizing 
qualities. Other aromatic herbs such as peppermint, cloves and turmeric add 
a pleasant aroma to the food, thereby increasing the taste of the meal. 
 Some herbs like aloe, sandalwood, turmeric, sheetraj hindi and khare khasak 
are commonly used as antiseptic and are very high in their medicinal values. 
 Ginger and cloves are used in certain cough syrups. They are known for their 
expectorant property, which promotes the thinning and ejection of mucus 
from the lungs, trachea and bronchi. Eucalyptus, Cardamom, Wild cherry 
and cloves are also expectorants. 
 Herbs such as Chamomile, Calamus, Ajwain, Basil, Cardamom, 
Chrysanthemum, Coriander, Fennel, Peppermint and Spearmint, Cinnamon, 
Ginger and Turmeric are helpful in promoting good blood circulation. 
Therefore, they are used as cardiac stimulants. 
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 Certain medicinal herbs have disinfectant property, which destroys disease 
causing germs. They also inhibit the growth of pathogenic microbes that 
cause communicable diseases. 
 Herbal medicine practitioners recommend calmative herbs, which provide a 
soothing effect to the body. They are often used as sedatives. 
 Certain aromatic plants such as Aloe, Golden seal, Barberry and Chirayata 
are used as mild tonics. The bitter taste of such plants reduces toxins in 
blood. They are helpful in destroying infection as well. 
 Certain herbs are used as stimulants to increase the activity of a system or an 
organ, for example herbs like Cayenne (Lal Mirch, Myrrh, Camphor and 
Guggul. 
 A wide variety of herbs including Giloe, Golden seal, Aloe and Barberry are 
used as tonics. They can also be nutritive and rejuvenate a healthy as well as 
diseased individual. 
CANCER 
  Cancer is the name given to a collection of related diseases. In all types of 
cancer, some of the body’s cells begin to divide without stopping and spread into 
surrounding tissue. Cancer can start almost anywhere in the human body, which is 
made up of trillions of cells. Normally, human cells grow and divide to form new 
cells as the body needs them. When cells grow old or become damaged, they die, 
and new cells take their place. 
 When cancer develops, however, this orderly process breaks down. As cells 
become more and more abnormal, old or damaged cells survive when they should 
die, and new cells form when they are not needed. These extra cells can divide 
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without stopping and may form growths called tumors. Many cancers form solid 
tumors, which are masses of tissue. Cancers of the blood, such as leukemias, 
generally do not form solid tumors .Cancerous tumors are malignant, which means 
they can spread into, or invade, nearby tissues. In addition, as these tumors grow, 
some cancer cells can break off and travel to distant places in the body through the 
blood or the lymph system and form new tumors far from the original tumor. 
 Unlike malignant tumors, benign tumors do not spread into, or invade, 
nearby tissues. Benign tumors can sometimes be quite large, however. When 
removed, they usually don’t grow back, whereas malignant tumors sometimes do. 
Unlike most benign tumors elsewhere in the body, benign brain tumors can be life 
threatening. 
Differences between Cancer Cells and Normal Cells 
 Cancer cells differ from normal cells in many ways that allow them to grow 
out of control and become invasive. One important difference is that cancer cells are 
less specialized than normal cells. That is, whereas normal cells mature into very 
distinct cell types with specific functions, cancer cells do not. This is one reason 
that, unlike normal cells, cancer cells continue to divide without stopping. 
 In addition, cancer cells are able to ignore signals that normally tell cells to 
stop dividing or that begin a process known as programmed cell death, or apoptosis, 
which the body uses to get rid of unneeded cells. 
 Cancer cells may be able to influence the normal cells, molecules, and blood 
vessels that surround and feed a tumor—an area known as the microenvironment. 
For instance, cancer cells can induce nearby normal cells to form blood vessels that 
supply tumors with oxygen and nutrients, which they need to grow. These blood 
vessels also remove waste products from tumors. 
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 Cancer cells are also often able to evade the immune system, a network of 
organs, tissues, and specialized cells that protects the body from infections and other 
conditions. Although the immune system normally removes damaged or abnormal 
cells from the body, some cancer cells are able to “hide” from the immune system. 
Tumors can also use the immune system to stay alive and grow. For example, with 
the help of certain immune system cells that normally prevent a runaway immune 
response, cancer cells can actually keep the immune system from killing cancer 
cells. 
MECHANISM OF CANCER ARISES 
 
Fig. 1: Mechanism of cancer arises 
Cancer is caused by certain changes to genes, the basic physical units of 
inheritance. Genes are arranged in long strands of tightly packed DNA called 
chromosomes. 
Credit: Terese Winslow 
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Cancer is a genetic disease—that is, it is caused by changes to genes that 
control the way our cells function, especially how they grow and divide. Genetic 
changes that cause cancer can be inherited from our parents. They can also arise 
during a person’s lifetime as a result of errors that occur as cells divide or because of 
damage to DNA caused by certain environmental exposures. Cancer-causing 
environmental exposures include substances, such as the chemicals in tobacco 
smoke, and radiation, such as ultraviolet rays from the sun. (Our Cancer Causes and 
Prevention section has more information.) 
 Each person’s cancer has a unique combination of genetic changes. As the 
cancer continues to grow, additional changes will occur. Even within the same 
tumor, different cells may have different genetic changes. 
 In general, cancer cells have more genetic changes, such as mutations in 
DNA, than normal cells. Some of these changes may have nothing to do with the 
cancer; they may be the result of the cancer, rather than its cause. 
"Drivers" of Cancer 
 The genetic changes that contribute to cancer tend to affect three main types 
of genes—proto-oncogenes, tumor suppressor genes, and DNA repair genes. These 
changes are sometimes called “drivers” of cancer. Proto-oncogenes are involved in 
normal cell growth and division. However, when these genes are altered in certain 
ways or are more active than normal, they may become cancer-causing genes (or 
oncogenes), allowing cells to grow and survive when they should not. Tumor 
suppressor genes are also involved in controlling cell growth and division. Cells 
with certain alterations in tumor suppressor genes may divide in an uncontrolled 
manner. 
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 DNA repair genes are involved in fixing damaged DNA. Cells with 
mutations in these genes tend to develop additional mutations in other genes. 
Together, these mutations may cause the cells to become cancerous. As scientists 
have learned more about the molecular changes that lead to cancer, they have found 
that certain mutations commonly occur in many types of cancer. Because of this, 
cancers are sometimes characterized by the types of genetic alterations that are 
believed to be driving them, not just by where they develop in the body and how the 
cancer cells look under the microscope. 
 
Fig. 2: Metastasis 
In metastasis, cancer cells break away from where they first formed (primary 
cancer), travel through the blood or lymph system, and form new tumors (metastatic 
tumors) in other parts of the body. The metastatic tumor is the same type of cancer 
as the primary tumor. 
A cancer that has spread from the place where it first started to another place 
in the body is called metastatic cancer. The process by which cancer cells spread to 
other parts of the body is called metastasis. Metastatic cancer has the same name and 
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the same type of cancer cells as the original, or primary, cancer. For example, breast 
cancer that spreads to and forms a metastatic tumor in the lung is metastatic breast 
cancer, not lung cancer. Under a microscope, metastatic cancer cells generally look 
the same as cells of the original cancer. Moreover, metastatic cancer cells and cells 
of the original cancer usually have some molecular features in common, such as the 
presence of specific chromosome changes. 
Treatment may help prolong the lives of some people with metastatic cancer. 
In general, though, the primary goal of treatments for metastatic cancer is to control 
the growth of the cancer or to relieve symptoms caused by it. Metastatic tumors can 
cause severe damage to how the body functions, and most people who die of cancer 
die of metastatic disease.   
Tissue Changes that Are Not Cancer 
Not every change in the body’s tissues is cancer. Some tissue changes may 
develop into cancer if they are not treated, however. Here are some examples of 
tissue changes that are not cancer but, in some cases, are monitored: 
 Hyperplasia occurs when cells within a tissue divide faster than normal and 
extra cells build up, or proliferate. However, the cells and the way the tissue is 
organized look normal under a microscope. Hyperplasia can be caused by several 
factors or conditions, including chronic irritation. 
 Dysplasia is a more serious condition than hyperplasia. In dysplasia, there is 
also a buildup of extra cells. But the cells look abnormal and there are changes in 
how the tissue is organized. In general, the more abnormal the cells and tissue look, 
the greater the chance that cancer will form. Some types of dysplasia may need to be 
monitored or treated. An example of dysplasia is an abnormal mole (called a 
 Chapter  1  Introduction 
 
Dept. of Pharmaceutical Chemistry  12  JKKMMRF College of Pharmacy 
dysplastic nevus) that forms on the skin. A dysplastic nevus can turn into melanoma, 
although most do not. 
An even more serious condition is carcinoma in situ. Although it is 
sometimes called cancer, carcinoma in situ is not cancer because the abnormal cells 
do not spread beyond the original tissue. That is, they do not invade nearby tissue 
the way that cancer cells do. But, because some carcinomas in situ may become 
cancer, they are usually treated. 
 
Fig. 3: Tissue changes of cancer  
Normal cells may become cancer cells. Before cancer cells form in tissues of 
the body, the cells go through abnormal changes called hyperplasia and dysplasia. In 
hyperplasia, there is an increase in the number of cells in an organ or tissue that 
appear normal under a microscope. In dysplasia, the cells look abnormal under a 
microscope but are not cancer. Hyperplasia and dysplasia may or may not become 
cancer. 
Types of Cancer 
There are more than 100 types of cancer. Types of cancer are usually named 
for the organs or tissues where the cancers form. For example, lung cancer starts in 
cells of the lung, and brain cancer starts in cells of the brain. Cancers also may be 
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described by the type of cell that formed them, such as an epithelial cell or a 
squamous cell. Here are some categories of cancers that begin in specific types of 
cells: 
Carcinoma 
Carcinomas are the most common type of cancer. They are formed by 
epithelial cells, which are the cells that cover the inside and outside surfaces of the 
body. There are many types of epithelial cells, which often have a column-like shape 
when viewed under a microscope. 
Carcinomas that begin in different epithelial cell types have specific names: 
Adenocarcinoma is a cancer that forms in epithelial cells that produce fluids 
or mucus. Tissues with this type of epithelial cell are sometimes called glandular 
tissues. Most cancers of the breast, colon, and prostate are adenocarcinomas. Basal 
cell carcinoma is a cancer that begins in the lower or basal (base) layer of the 
epidermis, which is a person’s outer layer of skin. 
Squamous cell carcinoma is a cancer that forms in squamous cells, which are 
epithelial cells that lie just beneath the outer surface of the skin. Squamous cells also 
line many other organs, including the stomach, intestines, lungs, bladder, and 
kidneys. Squamous cells look flat, like fish scales, when viewed under a microscope. 
Squamous cell carcinomas are sometimes called epidermis carcinomas. 
 Transitional cell carcinoma is a cancer that forms in a type of epithelial 
tissue called transitional epithelium, or urothelium. This tissue, which is made up of 
many layers of epithelial cells that can get bigger and smaller, is found in the linings 
of the bladder, ureters, and part of the kidneys (renal pelvis), and a few other organs. 
Some cancers of the bladder, ureters, and kidneys are transitional cell carcinomas. 
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Sarcoma 
 
Fig. 4: Soft tissue sarcoma  
Soft tissue sarcoma forms in soft tissues of the body, including muscle, 
tendons, fat, blood vessels, lymph vessels, nerves, and tissue around joints. 
Sarcomas are cancers that form in bone and soft tissues, including muscle, 
fat, blood vessels, lymph vessels, and fibrous tissue (such as tendons and ligaments). 
Osteosarcoma is the most common cancer of bone. The most common types 
of soft tissue sarcoma are leiomyosarcoma, Kaposi sarcoma, malignant fibrous 
histiocytoma, liposarcoma, and dermatofibrosarcoma protuberans. 
Our page on soft tissue sarcoma has more information. 
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Leukemia 
Cancers that begin in the blood-forming tissue of the bone marrow are called 
leukemias. These cancers do not form solid tumors. Instead, large numbers of 
abnormal white blood cells (leukemia cells and leukemic blast cells) build up in the 
blood and bone marrow, crowding out normal blood cells. The low level of normal 
blood cells can make it harder for the body to get oxygen to its tissues, control 
bleeding, or fight infections.   
There are four common types of leukemia, which are grouped based on how 
quickly the disease gets worse (acute or chronic) and on the type of blood cell the 
cancer starts in (lymphoblastic or myeloid). 
Lymphoma 
Lymphoma is cancer that begins in lymphocytes (T cells or B cells). These 
are disease-fighting white blood cells that are part of the immune system. In 
lymphoma, abnormal lymphocytes build up in lymph nodes and lymph vessels, as 
well as in other organs of the body. 
There are two main types of lymphoma: 
Hodgkin lymphoma – People with this disease have abnormal lymphocytes 
that are called Reed-Sternberg cells. These cells usually form from B cells. 
Non-Hodgkin lymphoma – This is a large group of cancers that start in 
lymphocytes. The cancers can grow quickly or slowly and can form from B cells or 
T cells. 
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Multiple Myeloma 
Multiple myeloma is cancer that begins in plasma cells, another type of 
immune cell. The abnormal plasma cells, called myeloma cells, build up in the bone 
marrow and form tumors in bones all through the body. Multiple myeloma is also 
called plasma cell myeloma and Kahler disease. 
Melanoma 
Melanoma is cancer that begins in cells that become melanocytes, which are 
specialized cells that make melanin (the pigment that gives skin its color). Most 
melanomas form on the skin, but melanomas can also form in other pigmented 
tissues, such as the eye. 
Brain and Spinal Cord Tumors 
There are different types of brain and spinal cord tumors. These tumors are 
named based on the type of cell in which they formed and where the tumor first 
formed in the central nervous system. For example, an astrocytic tumor begins in 
star-shaped brain cells called astrocytes, which help keep nerve cells healthy. Brain 
tumors can be benign (not cancer) or malignant (cancer). 
Other Types of Tumors 
Germ Cell Tumors 
Germ cell tumors are a type of tumor that begins in the cells that give rise to 
sperm or eggs. These tumors can occur almost anywhere in the body and can be 
either benign or malignant. 
  
 Chapter  1  Introduction 
 
Dept. of Pharmaceutical Chemistry  17  JKKMMRF College of Pharmacy 
Neuroendocrine Tumors 
Neuroendocrine tumors form from cells that release hormones into the blood 
in response to a signal from the nervous system. These tumors, which may make 
higher-than-normal amounts of hormones, can cause many different symptoms. 
Neuroendocrine tumors may be benign or malignant. 
Carcinoid Tumors 
Carcinoid tumors are a type of neuroendocrine tumor. They are slow-
growing tumors that are usually found in the gastrointestinal system (most often in 
the rectum and small intestine). Carcinoid tumors may spread to the liver or other 
sites in the body, and they may secrete substances such as serotonin or 
prostaglandins, causing carcinoid syndrome. 
PATHOPHYSIOLOGY 
Cancer is disease of regulation of tissue growth. In this disease, the cells of 
the body display uncontrolled growth, invasion that intrudes and destroys adjacent 
tissues and spreads to other body locations. In order for a normal cell to transform 
into a cancer cell, genes which regulate cell growth and differentiation must be alter 
cellular transformation and Derangement theory. In this theory, exposure of normal 
cells to some etiologic agent may transform normal cells into cancer cells. 
Failure of the Immune Response Theory. This theory conceptualizes that all 
individuals possess cancer cells but these cancer cells are NOT recognized by the 
immune system. Thus, cancer cells undergo destruction. Failure of the immune 
response system to kill or destroy the cancer cells leads to cancer. 
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Etiologic Factors or Carcinogens 
 Viruses or Oncogenic Viruses. Prolonged and recurrent viral infections may 
lead to the breakdown of the immune system. The overwhelmed immune 
system may fail to destroy the cancer cells present in the body. The human 
papillomavirus (HPV) are particularly common cancer-causing virus which is 
well-known for causing genital warts and all cases of cervical cancer. 
 Chemical carcinogens.  These chemicals cause cell mutation or alter the cell 
enzymes and proteins. 
Industrial Compounds 
1. Vinyl chloride – plastic manufacture, asbestos factories, construction 
works 
2. Polycyclic aromatic hydrocarbons 
3. Fertilizers 
4. Weed killers 
5. Dyes – analine dyes (most commonly found in beauty shops and used at 
homes), hair bleach 
6. Drugs – cytotoxic drugs, tar nicotine in tobacco, alcohol 
Hormones 
1. Estrogen 
2. Diethystilbesterol (DES) 
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Foods, preservatives 
1. Nitrites in bacon or smoked meat 
2. Talc (polished rice, salami and chewing gum) 
3. Food sweeteners 
4. Nitrosomines (rubber baby nipples) 
5. Aflatoxins (mold in nuts, grains, milk, cheese and peanut butter) 
6. Polycyclic hydrocarbons 
7. Physical agents 
Radiation 
1. From x-rays or radioactive isotopes 
2. From sunlight or UV rays 
Physical irritation or trauma 
1. Pipe smoking 
2. Multiple deliveries 
3. Genetics 
Risk Factors 
 Older individuals 
 Women are more prone to breast, uterine and cervical cancer 
 Men are more prone prostate and lung cancer 
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 Urban dwellers 
 Chemical factory workers 
 Farmers 
 Personnel of radiology department 
 Family history 
Mechanism of action of anticancer agents from pant source 
Cancers are characterized by the dysregulation of cell signaling pathways at 
multiple steps. However, most current anticancer therapies involve the modulation 
of a single target. The lack of safety and high cost of monotargeted therapies have 
encouraged alternative approaches. Both natural compounds, extracted from plants 
or animals, and synthetic compounds, derived from natural prototype structures, are 
now being used as cancer therapeutics and as chemopreventive compounds. In this 
report we will review four major classes of plant-derived anti-cancer drugs. 
 DNA methylation pattern is essential in development and can be altered in 
human tumors. Tumor cells are characterized by specific genetic and epigenetic 
changes that promote uncontrolled cellular proliferation. Based on the rationale that 
hypermethylation-induced gene silencing could be uncovered by gene demethylation 
and reactivation, many efforts have been put in the identification and 
characterization of inhibitors of DNA methylation as tools to treat cancer. Several 
studies suggested that green tea possess chemopreventive and therapeutic potential 
against tumor cells. Much of the anticancer and/or cancer chemopreventive effects 
of green tea are mediated by its most abundant catechin, epigallocatechin-3-gallate 
(EGCG). EGCG has been shown to possess strong anti-proliferative and anti-tumor 
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effects both in vitro and in animal models. EGCG inhibited DNA methyltransferase 
activity with reactivation of epigenetically silenced tumor suppressor genes. 
Chromatin acetylation is another major epigenetic modification that is 
regulated by the balanced action of histone acetyltransferases (HAT) and 
deacetylases (HDAC) (1). HDAC inhibitors (HDACi) reactivate epigenetically-
silenced genes in cancer cells, triggering cell cycle arrest and apoptosis. HDACi can 
enhance the sensitivity to chemotherapy for cancers and inhibit angiogenesis. A 
number of natural and synthetic HDACi have shown an anti-proliferative activity on 
tumor cells. Recent evidence suggests that dietary constituents, such as the 
isothiocyanates found in cruciferous vegetables, can act as HDACi. Broccoli sprouts 
are a rich source of sulforaphane, an isothiocyanate that inhibits HDAC activity in 
human colon, prostate, and breast cancer cells. Isoflavones have also been shown to 
possess a strong antioxidant activity and to inhibit oxidative DNA damage. 
Pomiferin, a prenylated isoflavonoid is isolated from Maclura pomifera. Pomiferin 
has been shown to inhibit the activity of HDAC enzyme. It also exhibited growth 
inhibitory activity on five human tumor cell lines including  
The HCT-15 colon tumor cell line.  
Thymoquinone (TQ), the main bioactive component of the volatile oil of the 
black seed (Nigella sativa, Ranunculaceae family), is a pleiotropic agent targeting 
multiple signaling pathways in many patho-physiological conditions. Recent studies 
have documented the cancer cell specific effects of TQ affecting multiple targets 
suggesting a promising role as an anticancer agent. 
Drugs that inhibit microtubule dynamics represent some of the most effective 
anticancer medications. These drugs bind to tubulin, and are classified as 
microtubule stabilizers or destabilizers. The two major classes of antimitotic drugs 
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used to treat cancer are the vinca alkaloids and the taxanes. Estramustine is another 
related drug that functions by binding to microtubules and MAPs and is used to treat 
prostate cancer. Vinca alkaloids were initially isolated from the pink periwinkle 
plant (Catharantus roseus; formerly vinca rosea Linn). The vinca alkaloids bind to 
β-tubulin near the GTP-binding site. Although the structures of the various vinca 
alkaloids vary only slightly, they have distinct niches as chemotherapeutic agents. 
Vincristine is most effective in treating leukemias, lymphomas and sarcomas. 
Vinblastine, which differs from vincristine only by substitution of a formyl for a 
methyl group, is effective in advanced testicular cancer, Hodgkin’s disease and 
lymphoma. Vinorelbine is currently used to treat non-small cell lung cancer as a 
single agent or in combination with cisplatin. Vindesine is undergoing clinical trials, 
primarily for treatment of acute lymphocytic leukemia. Vinflunine, the newest 
member of the vinca alkaloid family is currently in clinical trials to test for activity 
against solid tumors. Another well-characterized drug-binding sites on 
tubulin/microtubules is the taxane-binding site. Taxanes are microtubule-targeting 
agents that bind to polymerized microtubules, stabilize the microtubule, and inhibit 
its disassembly leading ultimately to cell death by apoptosis. Paclitaxel (Taxol, 
Bristol-Meyers Squibb) was originally derived from the bark of the Pacific yew tree 
but can now, like docetaxel, be partially synthesized from the precursor 10-
deactylbaccatin III, derived from needles of the European yew. 
Inhibitors of topoisomerase I and II are anticancer drugs active in a variety of 
haematological and solid tumours. The plant-derived camptothecins (irinotecan, 
topotecan) act as inhibitors of topoisomerase I; the plant-derived 
epopodophyllotoxins (etoposide and teniposide) and the microbial-derived 
anthracyclines (e.g. doxorubicin, epirubicin) act as inhibitors of topoisomerase II. 
Despite the numerous categories of the plant-derived anti-cancer drugs, this report 
reviews only 4 classes of natural anticancer drugs: methyltransferase inhibitors, 
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HDAC inhibitors (HDACi), DNA damaging/pro-oxidant drugs and mitotic 
disrupters. 
EGCG 
EGCG has been shown to be an efficient scavenger of free radicals. There is 
evidence that the A-ring of EGCG may provide an antioxidant site. On the other 
hand, studies have suggested that the cell-killing activity of tea phenols may be 
related to their pro-oxidant activity since in the presence of the H2O2scavenger 
catalase, the EGCG-induced apoptosis was inhibited. Whereas EGCG has been 
shown to have strong antioxidant activity in vitro, such activity has been 
demonstrated only in some in vivo experiments. Among smokers, green tea 
consumption decreased oxidative DNA damage measured by lower urinary level of 
8-hydroxydeoxyguanosine. 
 EGCG has been shown to exert antiproliferative effects by blocking the 
activation of transcription factors AP-1 and NF-kB by direct inhibition of specific 
kinases such as JNK. EGCG can also inhibit cyclin-dependent kinases, leading to 
hypophosphorylated Rb protein form causing G0/G1 arrest. 
 EGCG has been reported to induce apoptosis in many cancer cell lines, 
including leukemia, stomach, pancreas, and breast. EGCG sensitizes prostate 
carcinoma cells to TRAIL-mediated apoptosis, and it reduces telomerase activity in 
small-cell lung carcinoma. Caspase 3 activity seems to be required for green tea-
induced apoptosis. Green tea has been shown to inhibit carcinogenesis induced by 
UV light and chemical carcinogens in rodents, as well as spontaneous tumorigenesis 
in wild-type and genetically modified mice. The drug was able to inhibit cancer 
growth and invasion in a xenograft mouse model with pancreatic cancer via up-
regulation of caspase 3 activity and p21WAF1 expression. EGCG was shown to have 
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demethylating activity by inhibiting methyltransferase and to elevate the 
transcription of tumor suppressor genes, an effect that can be further enhanced by 
the presence of HDACi. 
Several studies have reported that EGCG inhibits the formation of new blood 
vessels by blocking VEGF expression in head and neck, breast, and colon cancer 
cells. In the TAMP mouse model, the expression of VEGF and matrix 
metalloproteases  and p-ERKs 1 and 2  decreased when mice consumed green tea 
extract, and there were only low side-effects.Many case-control studies have shown 
that subjects who consume large amounts of tea had a lower risk of gastric, 
esophageal and breast cancer. A recent encouraging study reported that among 
patients consuming 600mg green tea catechins daily within one year, there was a 
remarkable 90% reduction in the rate of high-grade-PIN-positive men developing 
prostate cancer. EGCG is currently tested in phase I pharmacokinetic study to 
determine its systemic availability after single oral dose administration. This clinical 
study is the first to show that chemicals in green tea can increase detoxification 
enzymes (glutathione S-transferases) in humans. Clinical trials of green tea products, 
especially in prostate cancer patients have yielded encouraging results. 
 Interestingly, investigating the pharmacogenetics of EGCG revealed that 
mice are very similar to humans in terms of enzymatic ability to conjugate tea 
catechins. Because the levels of tea consumption are lower than those used in animal 
cancer chemoprevention, the amount of the tea phenols that reaches the target 
tissues is a limiting factor. Furthermore, there is no doubt that the involvement of 
EGCG pro-oxidation may differ in vivo where anti-oxidative capacity is much 
higher and oxygen partial pressure is much lower than that in cell culture medium. 
Nevertheless, it is expected that cancer can be prevented by consuming moderate 
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levels of tea especially for the oral cavity and the intestinal tract, and this concept 
has to be further tested in intervention human studies. 
ANTIOXIDENTS 
Antioxidants are compounds that inhibit oxidation. Oxidation is a chemical 
reaction that can produce free radicals, thereby leading to chain reactions that may 
damage the cells of organisms. Antioxidants such as thiols or ascorbic acid (vitamin 
C) terminate these chain reactions. To balance the oxidative state, plants and animals 
maintain complex systems of overlapping antioxidants, such as glutathione 
and enzymes (e.g., catalase and superoxide dismutase), produced internally, or 
the dietary antioxidants vitamin C, and vitamin E. 
 The term "antioxidant" is mostly used for two entirely different groups of 
substances: industrial chemicals that are added to products to prevent oxidation, and 
naturally occurring compounds that are present in foods and tissue. The former, 
industrial antioxidants, have diverse uses: acting as preservatives in food and 
cosmetics, and being oxidation-inhibitors in fuels.  
 Importantly, antioxidant dietary supplements have not yet been shown to 
improve health in humans, or to be effective at preventing disease. Supplements 
of beta-carotene, vitamin A, and vitamin E have no positive effect on mortality 
rate or cancer risk. Additionally, supplementation with selenium or vitamin E do not 
reduce the risk of cardiovascular disease.  
Although certain levels of antioxidant vitamins in the diet are required for good 
health, there is still considerable debate on whether antioxidant-rich foods or 
supplements have anti-disease activity. Moreover, if they are actually beneficial, it is 
unknown which antioxidants are health-promoting in the diet and in what amounts 
beyond typical dietary intake. Some authors dispute the hypothesis that antioxidant 
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vitamins could prevent chronic diseases, and others maintain such that hypothesis is 
unproven and misguided. Polyphenols, which often have antioxidant properties in 
vitro, are not necessarily antioxidants in vivo due to extensive metabolism following 
digestion.  
In many polyphenols the catechol group acts as an electron acceptor and is 
therefore responsible for the antioxidant activity. However, this catechol group 
undergoes extensive metabolism upon uptake in the human body, for example by 
catechol-O-methyl transferase, and is therefore no longer able to act as an electron 
acceptor. Many polyphenols may have non-antioxidant roles in minute 
concentrations that affect cell-to-cell signaling, receptor sensitivity, inflammatory 
enzyme activity or gene regulation. Although dietary antioxidants have been 
investigated for potential effects on neurodegenerative diseases such as Alzheimer's 
disease, Parkinson's disease, and amyotrophic lateral sclerosis 
IMPORTANCE OF ANTIOXIDENTS 
Antioxidants are seemingly magical nutrients that can repair cell damage that 
happens in all our bodies over time -- including those of our cats. These nutrients 
occur naturally, but a body's supply needs an antioxidant boost from food. Common 
antioxidants include vitamin A, vitamin C, vitamin E and certain compounds called 
carotenoids (like lutein and beta-carotene) 
As cells function normally in the body, they produce damaged molecules 
called free radicals, which are highly unstable and steal components from other 
cellular molecules, such as fat, protein, or DNA, thereby spreading the damage. This 
process, called peroxidation, continues in a chain reaction, and entire cells soon 
become damaged and die. Peroxidation is important because it helps the body 
destroy cells that have outlived their usefulness and kills germs and parasites. 
 Chapter  1  Introduction 
 
Dept. of Pharmaceutical Chemistry  27  JKKMMRF College of Pharmacy 
However, peroxidation, when left unchecked, also destroys or damages healthy 
cells. 
Antioxidants help prevent widespread cellular destruction by donating 
components to stabilize free radicals. More important, antioxidants return to the 
surface of the cell to stabilize, rather than damage, other cellular components.When 
there are not enough antioxidants to hold peroxidation in check, free radicals begin 
damaging healthy cells, which can lead to problems. For example, free radical 
damage to immune cells can lead to an increased risk of infections.  
Recent research has examined the benefits of certain antioxidants on the immune 
response of dogs and cats. The results of these studies indicated that antioxidants are 
important in helping dogs and cats maintain a healthy immune system. The research 
also showed each antioxidant benefits the immune system uniquely so one 
antioxidant at high levels is not as effective as a group of antioxidants acting 
together. 
Nutritionally supporting the immune system may be especially critical for 
young animals. For example, the immune system in kittens is still developing at the 
time it is being challenged with vaccinations and exposure to disease-causing agents. 
With the addition of antioxidants, a proper kitten diet can aid in the development of 
a strong immune system to help maintain good health and protect against viruses, 
bacteria and parasites.  
Antioxidants and Aging 
Recent research has also examined the effect of aging on immune responses. 
The findings indicate that as dogs and cats age, immune cell responses may decline. 
Including antioxidants in the diet can reverse the age-related decrease in immune 
cell function. However, increased immune cell response is not always proportional 
 Chapter  1  Introduction 
 
Dept. of Pharmaceutical Chemistry  28  JKKMMRF College of Pharmacy 
to the amount of vitamin E. Although feeding a diet containing 250 IU vitamin E/kg 
enhanced immune cell response in old cats, adding 500 IU/kg did not achieve the 
same beneficial effect. Many pet food labels include information about antioxidants, 
perhaps indicating that the product was formulated to contain this beneficial 
nutrient. Here are some common ingredients to look for, and how they may help 
your cat: 
 Vitamin E Optimizes immune system's T-cell activation 
 Lutein Optimizes immune system's B-cell activation and helps vaccine 
recognition 
 Beta-carotene Optimizes types of cell present in the blood, increases 
antibody levels in the blood and helps vaccine recognition 
Antioxidants may not prevent all health problems, but there is enough 
evidence to suggest that they promote good health. Since these nutrients don't 
change the flavour or texture of food much, advice to consume them should be easy 
for you and your cat to swallow. 
ANTI OXIDENTS IN CANCER THERAPY 
There are studies that show that low antioxidant status and increased 
oxidative stress are seen in cancer patients, even before oncology treatment starts. 
Patients with tongue carcinoma and found that the pre-treatment levels of plasma 
lipid peroxide and conjugated dines were Three-stage model of carcinogenesis and 
the level of carcinogenic effect. A multistage process such as cancer development is 
characterized by the cumulative action of multiple events occurring in a single cell 
and can be described by three stages: (1) initiation, (2) promotion, and (3) 
progression. ROS can act in all these stages of carcinogenesis. (1) Initiation stage 
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produces an altered cell followed by at least one round of DNA synthesis to fix the 
damage (eg, 8-OH-G) produced during the initiation. (2) The promotion stage is 
characterized by the clonal expansion of initiated cells by the induction of cell 
proliferation and/or inhibition of programmed cell death (apoptosis). (3) Progression 
stage involves cellular and molecular changes that occur from the preneoplastic to 
the neoplastic state, is irreversible and s characterized by accumulation of additional 
genetic damage, leading to the transition of the cell from benign to malignant, and is 
characterized by genetic instability and disruption of chromosome integrity. 
(Adapted from Vineis et al. [14].)  
V. Fuchs-Tarlovsky / Nutrition 29 (2013) 15–21 significantly elevated in 
patients with carcinoma, as compared with controls (P ¼ 0.001). Significantly 
lowered levels of reduced glutathione, glutathione peroxidase, superoxide 
dismutase, and vitamin C and E were observed in cancer patients, when compared to 
control subjects. They concluded that increased levels of oxidative stress markers 
and decreased levels of antioxidants in carcinoma or the tongue suggest that 
oxidative stress markers play a significant role in pathophysiology of this cancer. In 
a study by Badajatia et al. , results showed that serum levels of vitamin C and E, 
whole blood levels of superoxide dismutase and glutathione peroxidase, and serum 
antioxidant activity were significantly lower (P < 0.001), whereas serum levels of 
MDA were significantly higher (P < 0.001) in patients than controls. Levels of all 
the biochemical parameters were correlated with the degree and severity of the 
disease. Results by Klarod et al. showed that when measuring serum levels of 
nonenzymatic antioxidants in lung cancer patients, retinol and lycopene levels were 
statically lower at early stages, whereas vitamin E, b-carotene, selenium, and zinc 
were even lower at advanced stages of the disease, and that serum selenium levels 
happened to be different when patients were divided according to their body mass 
index. Vitamin E or a-tocopherol has been defined as a radical-chain breaker, which, 
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due to its hydrophobic nature, operates in a lipid environment. The effects of a-
tocopherol as an antioxidant are thus restricted to its direct effects in membranes and 
lipoprotein domains. Consequently, other definitions such as “secondary 
antioxidants” as an inhibitor of “enzymes that produce radicals,” or activation of 
genes coding for “antioxidant enzymes,” are confusing.  
Tocopherols react with free radicals, notably peroxide radicals, and with 
singlet molecular oxygen (‘O2), which is the base of its function as an antioxidant. 
RRR-a-Tocopherol is the major peroxyl radical scavenger in biological lipid phases 
such as membranes or low-density lipoproteins. In membranes such high reactivity 
is important because tocopherols react with lipid peroxyl radicals to yield a 
relatively stable lipid hydroperoxide, and the tocopheroxyl radical interrupts the 
radical chain reaction, thereby affording protection against lipid peroxidation 
Vitamin E is the major lipid soluble antioxidant protecting lipids against 
peroxidative damage. Studies indicate that oxidative cleavage of the phenyl side 
chain is a major metabolic pathway in humans, operative at saturated vitamin E 
plasma concentrations. In a study by Chitra et al, 2008 aimed to evaluate early and 
late effects of radiation and a-tocopherol on the secretion of saliva and on the 
selected saliva salivary parameters in oral cavity patients, the conclusion was that 
supplementation with a-tocopherol improved the salivary flow rate, thereby 
maintaining the salivary parameters. Vitamin C or L-ascorbic acid is water soluble 
and is present in its deprotonated state under most physiological conditions.  
It is considered to be the most important antioxidant in extracellular fluids 
and has many cellular activities of an antioxidant nature as well. Vitamin C has been 
shown to scavenge superoxide, hydrogen, peroxide, hydroxyl radical, peroxyl 
radicals, and ‘O2 efficiently. Ascorbic acid can also protect membranes against 
peroxidation by enhancing the activity of tocopherol, the chief lipid-soluble vitamin. 
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Although the value of vitamin C as a potential cancer treatment has been debated for 
decades, only one randomized clinical trial was found that evaluated vitamin C 
treatment concurrently with chemotherapy and reported on outcomes. In this study, 
a non-significant advantage was shown in objective response (complete response þ 
partial response), which was higher in the vitamin C supplemented group (60%) 
than in the placebo arm (33%). Additionally, although both groups had significant 
reductions in the sizes of the average lump diameter before and after treatment, the 
mean change was 3.53 0.73 in the vitamin C group versus 1.93 0.77 in the control 
group. Two recent studies have included vitamin C as part of an antioxidant mixture 
given concurrently with chemotherapy.  
Pathak et al.  Evaluated vitamins C, E, and b-carotene, whereas Weijl et al. 
evaluated vitamins C, E, and selenium. Weijl reported poor adherence to the 
supplemental regimen: 46% of all patients did not drink the beverage (placebo or 
antioxidant) throughout the entire study. Although the overall response rates were 
similar between the two groups (48% antioxidant group versus 44% control group), 
nine patients had complete response in the antioxidant group versus six patients in 
the placebo arm. A statistically significant correlation regarding improvement in 
toxicities was found between patients with the highest serum levels of antioxidant 
supplements and the lowest loss of high tone hearing after three cycles of 
chemotherapy (P ¼ 0.019). In the study by Pathak et al. , although none of the 
results achieved statistical significance, an advantage in overall response rates (37% 
versus 33%) and median survival (11 mo versus 9 mo) were seen for patients taking 
the antioxidant supplement 
Much debate has arisen about whether antioxidant supplementation alters the 
efficacy of cancer chemotherapy. There is limited preliminary evidence by quality 
and sample size suggesting that certain antioxidant supplements may reduce adverse 
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reactions including neurotoxicity, asthenia, stomatitis/mucositis, and weight loss. 
Significant reductions in toxicity may alleviate dose-limiting toxicities so that more 
patients are able to complete prescribed chemotherapy regimens successfully, 
suggesting an improved therapeutic index. Because of the potential of the 
relationship between the reductions of dose-limiting toxicities allowing for full 
chemotherapy cycles and the subsequent potential for increased tumour. Response 
and/or survival, it is critical that future antioxidant/chemotherapy studies employ 
proper sample sizes and methodologies so that the results are of clear clinical 
relevance. Many studies indicate that antioxidant supplementation results in either 
increased survival times, increased tumor response, or both, as well as fewer 
toxicities than controls; in some of the last systematic reviews in this specific topic 
there is no evidence of antioxidant interference with chemotherapy mechanisms, 
with a possibility that antioxidants may even improve tumor response or patient 
survival. Combining these results with the potential for improvement of toxic side 
effects by antioxidants, additional strategies for further research on antioxidants and 
chemotherapy are now warranted 
MECHANISM OF ACTION OF ANTIOXIDANTS 
Antioxidants are molecules that inhibit or quench free radical reactions and 
delay or inhibit cellular damage. Though the antioxidant defenses are different from 
species to species, the presence of the antioxidant defense is universal. Antioxidants 
exists both in enzymatic and non-enzymatic forms in the intracellular and 
extracellular environment. 
 biochemical reactions, increased exposure to the environment, and higher 
levels of dietary xenobiotics result in the generation of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS). ROS and RNS are responsible for the 
oxidative stress in different pathophysiological conditions. Cellular constituents of 
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our body are altered in oxidative stress conditions, resulting in various disease states. 
The oxidative stress can be effectively neutralized by enhancing cellular defenses in 
the form of antioxidants. Certain compounds act as in vivo antioxidants by raising 
the levels of endogenous antioxidant defenses. Expression of genes encoding the 
enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidase (GSHPx) increases the level of endogenous antioxidants. 
Antioxidants can be categorized in multiple ways. Based on their activity, 
they can be categorized as enzymatic and non-enzymatic antioxidants. Enzymatic 
antioxidants work by breaking down and removing free radicals. The antioxidant 
enzymes convert dangerous oxidative products to hydrogen peroxide (H2O2) and 
then to water, in a multi-step process in presence of cofactors such as copper, zinc, 
manganese, and iron. Non-enzymatic antioxidants work by interrupting free radical 
chain reactions. Few examples of the non-enzymatic antioxidants are vitamin C, 
vitamin E, plant polyphenol, carotenoids, and glutathione. 
 The other way of categorizing the antioxidants is based on their solubility in 
the water or lipids. The antioxidants can be categorized as water-soluble and lipid-
soluble antioxidants. The water-soluble antioxidants (e.g. vitamin C) are present in 
the cellular fluids such as cytosol, or cytoplasmic matrix. The lipid-soluble 
antioxidants (e.g. vitamin E, carotenoids, and lipoic acid) are predominantly located 
in cell membranes. 
 The antioxidants can also be categorized according to their size, the small-
molecule antioxidants and large-molecule antioxidants. The small-molecule 
antioxidants neutralize the ROS in a process called radical scavenging and carry 
them away. The main antioxidants in this category are vitamin C, vitamin E, 
carotenoids, and glutathione (GSH). The large-molecule antioxidants are enzymes 
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(SOD, CAT, and GSHPx) and sacrificial proteins (albumin) that absorb ROS and 
prevent them from attacking other essential proteins. 
To understand the mechanism of action of antioxidants, it is necessary to 
understand the generation of free radicals and their damaging reactions. This review 
elaborates the generation and damages that free radicals create, mechanism of action 
of the natural antioxidant compounds and assays for the evaluation of their 
antioxidant properties. The reaction mechanisms of the antioxidant assays are 
discussed. The scope of this article is limited to the natural antioxidants and the in 
vitro assays for evaluation of their antioxidant properties. 
2. Generation of free radicals 
The generation of ROSbegins with rapid uptake of oxygen, activation of 
NADPH oxidase, and the production of the superoxide anion radical (O2˙−, eqn (1)), 
 
Table 1 List of the ROS 
Symbol Name 
1O2 Singlet oxygen 
O2˙− Superoxide anion radical 
˙OH Hydroxyl radical 
RO˙ Alkoxyl radical 
ROO˙ Peroxyl radical 
H2O2 Hydrogen peroxide 
LOOH Lipid hydroperoxide 
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The O2˙− is then rapidly converted to H2O2 (eqn (2)) by SOD 
 
 These ROS can act by either of the two oxygen dependent mechanisms 
resulting in the destruction of the microorganism or other foreign matter. The 
reactive species can also be generated by the myeloperoxidase–halide–H2O2 system. 
The enzyme myeloperoxidase (MPO) is present in the neutrophil cytoplasmic 
granules. In presence of the chloride ion, which is ubiquitous, H2O2 is converted to 
hypochlorous (HOCl, eqn (3)), a potent oxidant and antimicrobial agent.8 
 
ROS are also generated from O2˙−and H2O2 via ‘respiratory burst’ by Fenton 
(eqn (4)) and/or Haber–Weiss (eqn (5)) reactions. 
H2O2 + Fe2+ → ˙OH + OH− + Fe3+ 
O2˙− + H2O2 → ˙OH + OH− + O2 
 The enzyme nitric oxide synthase produce reactive nitrogen species (RNS), 
such as nitric oxide (NO˙) from arginine (eqn (6)) 
L-Arg + O2 + NADPH → NO˙ + citrulline 
An inducible nitric oxide synthase (iNOS) is capable of continuously producing 
large amount of NO˙, which act as a O2˙−quencher. The NO˙ and O2˙− react together 
to produce peroxynitrite (ONOO−, eqn (7)), a very strong oxidant, hence, each can 
modulate the effects of other. Although neither NO˙ nor O2˙− is a strong oxidant, 
peroxynitrite is a potent and versatile oxidant that can attack a wide range of 
biological targets. 
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NO˙ + O2˙− → ONOO− 
Peroxynitrite reacts with the aromatic amino acid residues in the enzyme 
resulting in the nitration of the aromatic amino acids. Such a change in the 
aminoacid residue can result in the enzyme inactivation. However, nitric oxide is an 
important cytotoxic effector molecule in the defense against tumor cells, various 
protozoa, fungi, helminthes, and mycobacteria. The other sources of free radical 
reactions are cyclooxygenation, lipooxygenation, lipid peroxidation, metabolism of 
xenobiotics, and ultraviolet radiations 
3. Damaging reactions of free radicals 
ROS induced oxidative stress is associated with the chronic diseases such as 
cancer, coronary heart disease (CHD), and osteoporosis. Free radicals attack all 
major classes of biomolecules, mainly the polyunsaturated fatty acids (PUFA) of 
cell membranes. The oxidative damage of PUFA, known as lipid peroxidation is 
particularly destructive, because it proceeds as a self-perpetuating chain reaction. 
 The general process of lipid peroxidation can be envisaged as depicted 
bellow (eqn (8)–(11)), where LH is the target PUFA and R˙ is the initializing, 
oxidizing radical. Oxidation of the PUFA generates a fatty acid radical (L˙) (eqn 
(8)), which rapidly adds oxygen to form a fatty acid peroxyl radical (LOO˙, eqn (9)). 
The peroxyl radicals are the carriers of the chain reactions. The peroxyl radicals can 
further oxidize PUFA molecules and initiate new chain reactions, producing lipid 
hydroperoxides (LOOH) (eqn (10)and (11)) that can break down to yet more radical 
species. 
LH + R˙ → L˙ + RH 
L˙ + O2 → LOO˙ 
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LOO˙ + LH → LOOH + L˙ 
LOOH → LO˙ + LOO˙ + aldehydes 
Lipid hydroperoxides always break down to aldehydes. Many of these 
aldehydes are biologically active compounds, which can diffuse from the original 
site of attack and spread the attack to the other parts of the cell. Lipid peroxidation 
has been widely associated with the tissue injuries and diseases. 
 Oxygen metabolism generates ˙OH, O2˙−, and the non-radical H2O2. The 
˙OH is highly reactive and reacts with biological molecules such as DNAs, proteins, 
and lipids, which results in the chemical modifications of these molecules. There are 
several research reports on the oxidative damage of DNA due to the ˙OH 
 The ˙OH reacts with the basepairs of DNA, resulting in the oxidative damage 
of the heterocyclic moiety and the sugar moiety in the oligonucleotides by a variety 
of mechanisms. This type of oxidative damage to DNA is highly correlated to the 
physiological conditions such as mutagenesis, carcinogenesis, and aging.The 
addition reactions yield OH-adduct radicals of DNA bases (Scheme 1), whereas the 
allyl radical of thymine and carbon-centered sugar radicals (Scheme 2) are formed 
from the abstraction reactions. 
As shown in the Scheme 1, the ˙OH reacts with the guanine of the DNA to 
produce the C-8-hydroxy-adduct radical of guanine, which is converted to the 2, 6-
diamino-4-hydroxy-5-formamidopyrimidine upon reduction and ring opening 
reactions. However, the C-8-hydroxy-adduct radical of guanine is converted to the 
8-hydroxyguanine upon oxidation reaction. The ˙OH radical reacts with the 
heterocyclic moiety of the thymine and cytosine at C5- and C6-positions, resulting 
in the C5–OH and C6–OH adduct radicals, respectively. The oxidation reaction of 
these adduct radicals with water (followed by deprotonation) results in the formation 
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of the cytosine glycol and thymine glycol, respectively. Overall, the reactions of the 
˙OH with the DNA bases result in the impaired dsDNA. 
 
Scheme 1 Reaction of hydroxyl radical with guanine. 
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Scheme 2 Reaction of hydroxyl radical with the sugar moiety of DNA. 
 As shown in the Scheme 2, the ˙OH reacts with the sugar moiety of DNA by 
abstracting an H-atom from rom C5 carbon atom. One unique reaction of the C5′-
centered radical of the sugar moiety in DNA is the addition to the C8-position of the 
purine ring in the same nucleoside (e.g. guanine). This intermolecular cyclization 
results in the formation of the 8, 5′-cyclopurine-2′-deoxynucleosides. The reactions 
of carbon-centered sugar radicals result in the DNA strand breaks and base-free sites 
by a variety of mechanisms. 
Proteins are oxidatively damaged by the combined action of activated oxygen 
species and the trace metal ions such as Fe2+and Cu2+. The amino acids lysine, 
proline, histidine, and arginine have been found to be the most sensitive to oxidative 
damage. Recent studies indicate that, a wide range of residue modifications can 
occur including formation of peroxides, and carbonyls.Generation of the carbonyl 
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residue is a useful measure of oxidative damage to proteins. Thus, the oxidative 
damage to tissue results in the increased amount of oxidized protein. A detailed 
review by Cooke et al. provides important information on the oxidative DNA 
damage, mechanisms, mutations, and related diseases. 
Low levels of antioxidants have been associated with the heart disease and 
cancer. Antioxidants provide protection against a number of disease processes such 
as aging, allergies, algesia, arthritis, asthma, atherosclerosis, autoimmune diseases, 
bronchopulmonary dyspepsia, and cancer. The other disorders to which antioxidants 
provide protection are cataract, cerebral ischemia, diabetes mellitus, eczema, 
gastrointestinal inflammatory diseases, and genetic disorders. Following section 
elaborates the mechanism of action of the radical scavenging activities of various 
natural antioxidant molecules. 
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2. LITERATURE REVIEW 
Nephrotoxicityof Physalislagascae 
Olagunjua et al. (2009) suggested a role for reactive oxygen metabolites as 
one of the postulated mechanisms in the pathogenesis of CCl4 nephrotoxicity. It has 
been hypothesized that physalis extract affords protection by impairing CCl4 
mediated lipid peroxidation, through decreased production of free radical 
derivatives. 
Gastric Ulcer ofPhysalis lagascae 
 A laboratory study was reported in which methanolic extract of Physalis 
minima leaves was investigated on ethanol induced ulcer models and pylorus 
ligation in wistar rats. The present study indicates that Physalis minima leaves 
extract have potential anti ulcer activity in both models. This results may further 
suggests that methanolic extract was found to possess anti-ulcerogenic as well as 
ulcer healing property, which might be anti-secretory activity  
Anti-asthmaof Physalislagascae 
 The extract (100 and 200 mg/kg I.p) inhibited of albumin induced asthma by 
decreasing releasing of inflammatory mediators. Physalis lagascaeroots extract has 
potent anti-asthmatic activity. Its anti-asthmatic property probably acts via a 
reduction in inflammatory mediator’s release. Thus the Physalis lagascaehas 
significant anti-asthmatic property. 
Diuretic effect ofPhysalis lagascae 
 Physalis was described to possess Diuretic effect petroleum ether extract of 
the Physalis minima in albino rats. The diuretic effect of the extract was evaluated 
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by measuring urine volume, sodium and potassium content. Methanolic Extract of 
Physalis minima produced notable diuretic effect which appeared to be comparable 
to that produced by the standard diuretic furosemide. 
Anti-Microbial effect of Physalis lagascae 
Methanol extract of Physalis minima exhibited Anti-Microbial activity, 
which was more active than that of standard linezolid, against a variety of clinically 
important microorganisms isolated from nearby hospitals in India and nonmutagenic 
up to 5 mg/plate in Ames test 
Hepatoprotective effect of Physalis lagascae 
 As Physalis in rich in Flavonoids it is having hepatoprotective effect studies 
suggest that the aqueous and ethanol extracts prepared from the whole plant of these 
species were evaluated for their antihepatoma activity. The results conclude that 
plant possesses potent antihepatoma activity and its effect on apoptosis is associated 
with mitochondrial dysfunction. 
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3. AIM AND PLAN OF WORK 
 Medicinal plants have been in India for centuries as a therapeutic source for 
treating wide variety of ailments and have been found to be immense global 
importance 
 The family Solanacea consist important medicinal plants with wide range of 
pharmacological, biological activities and phytochemical constituents. The drug is 
used for a wide range of diseases which can be viewed from the literatures. 
 The selection of the plant physalis lagascae was made on the basis of its easy 
availability, therapeutic value and degree of research work which is not done. 
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PLAN OF WORK 
The literature review reveals that the plant physalis lagascae was used to 
treat various ailments. However, there was a few pharmacological exploration was 
performed. Hence the present study undertaken for its scientific merits towards 
phytomedicine claim. The plan of work on the plant physalis lagascae was carried 
out as follow 
1. Collection and identification of plant material 
2. Preliminary phytochemical studies 
a) Preparation of extract 
b)  Qualitative phytochemical analysis 
c)  Chromatographic studies 
3. Pharmacological evaluation of the plant extract 
a) Anticancer activity 
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4. PLANT PROFILE 
 
Fig. 5: Images of Physalis lagascae 
 
 
Fig. 6: Leaf of Physalis lagascae 
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Fig. 7: Whole plant of Physalis lagascae 
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Botanical name: Physalis lagascae 
Common names 
Little gooseberry, Wild Cape gooseberry, Ground Cherry, Sunberry  
• Hindi:  Rasbhari, Ban Tipariya, Chirpati  
• Marathi: Chirboti, Nanvachivel, Ran-popti  
• Tamil: Kupanti  
• Malayalam: Notinotta  
• Telugu: Kupanti  
• Kannada: Gadde hannu  
• Bengali: Bantepariya  
• Gujarati: Popti; 
Family: Solanacea 
General 
 Erect to decumbent or prostrate, weak or occasionally ± robust, ± 
dichotomously much branched, annual herb, (0.05)0.1–1 m high (elsewhere said to 
reach 1.5 m), often tinged purple, ± clothed all over with simple, stout, often 
multicellular, white or hyaline, ± spreading, usually eglandular hairs 1–4 mm long, 
and also rigid, curved at the tip, appressed to spreading, often minute, hairs, 
furnished with ± sessile glands too 
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Pedicel 
 Pedicel 2–5(9) mm long, villous or puberulous, occasionally subglabrous, in 
fruit elongated to 9(10) mm 
Ovary 
Ovary 0.8–0.9 × 0.6–0.7 mm, ellipsoid or ± globose, glabrous. 
Style 
Style 2–3 mm long, filiform, ± curved upwards 
Note 
 The specimens Torre et al. in Torre 17705, 18035 and 19042, from the Tete 
Province of Mozambique have relatively large leaves, with petioles up to 8 cm long 
and laminas up to 10.5 × 7.5 cm. The specimen Flanagan 3305, from Zimbabwe, 
referred to by Wild, loc. cit. (1953) as P. minima, but not seen by me, is probably 
this species. Chromosome number: 2n=24 
Distribution 
 Mozambique Zambia Zimbabwe Malawi ZAM N, ZAM W, ZAM C, ZAM 
S, ZIM N, ZIM E, MAL C, MAL S, MOZ Z, MOZ T, MOZ MS Native to tropical 
America (Mexico and Antilles), now extending northwards to the United States and 
southwards throughout Central America and the Caribbean to Bolivia. 
Habit 
 Erect to decumbent or prostrate, weak or occasionally ± robust, ± 
dichotomously much branched, annual herb, (0.05)0.1–1 m high (elsewhere said to 
reach 1.5 m), often tinged purple, ± clothed all over with simple, stout, often 
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multicellular, white or hyaline, ± spreading, usually eglandular hairs 1–4 mm long, 
and also rigid, curved at the tip, appressed to spreading, often minute, hairs, 
furnished with ± sessile glands too. 
Branches 
 Branches angular or angular-ribbed, striate, drying ± sulcate, sparingly 
villous, with ± long hairs mainly on the emergent parts and also short and minute 
hairs somewhat localized near the nodes, occasionally subglabrous. Branches 
angular or angular-ribbed, striate, drying ± sulcate, sparingly villous, with ± long 
hairs mainly on the emergent parts and also short and minute hairs somewhat 
localized near the nodes, occasionally subglabrous 
Leaves 
 Leaves solitary or geminate; petiole 0.5–4.5(8) cm long, often slightly 
winged, rather sheathing at the base; lamina membranous or ± fleshy, 1.5–7.5(10.5) 
× 0.8–4.5(7.5) cm, ovate to lanceolate, sometimes rhombic, ovate-oblong, elliptic or 
oblanceolate, base shortly cuneate or attenuate, sometimes obtuse, rounded, truncate 
or subcordate, and often oblique or unequal-sided, sometimes ± decurrent into the 
petiole, apex acuminate, acute or obtuse, entire to somewhat coarsely sinuate-
dentate, rarely dentate, the teeth unequal, ± triangular, obtuse, the sinuses rounded, 
both surfaces ± sparsely pilose or subglabrous but pubescent along the nerves and 
near the margins; minor leaves with lamina 0.5–0.7 × 0.3–0.4 cm, elliptic, 
sometimes present. Leaves solitary or geminate; petiole 0.5–4.5(8) cm long, often 
slightly winged, rather sheathing at the base; lamina membranous or ± fleshy, 1. 5–
7.5(10.5) × 0.8–4.5(7.5) cm, ovate to lanceolate, sometimes rhombic, ovate-oblong, 
elliptic or oblanceolate, base shortly cuneate or attenuate, sometimes obtuse, 
rounded, truncate or subcordate, and often oblique or unequal-sided, sometimes ± 
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decurrent into the petiole, apex acuminate, acute or obtuse, entire to somewhat 
coarsely sinuate-dentate, rarely dentate, the teeth unequal, ± triangular, obtuse, the 
sinuses rounded, both surfaces ± sparsely pilose or subglabrous but pubescent along 
the nerves and near the margins; minor leaves with lamina 0.5–0.7 × 0.3–0.4 cm, 
elliptic, sometimes present 
Flowers 
 Flowers solitary, inserted by the side of the petiole-base appearing axillary, 
erect to pendulous; pedicel 2–5(9) mm long, villous or puberulous, occasionally 
subglabrous, in fruit elongated to 9(10) mm. Flowers solitary, inserted by the side of 
the petiole-base appearing axillary, erect to pendulous. 
Calyx 
 Calyx (1.5)2–3.5(4) mm long, 1.5–2.5(3) mm across at the base of the lobes, 
campanulate, sub-angled-ribbed, truncate or invaginated at the base, with scattered, 
stout, white or hyaline, ± spreading, long hairs, or puberulous especially along the 
ribs, on the inside glabrous except for the lobes with ± dense, minute indumentum 
towards the apex, near the margins and sometimes also along the midribs; lobes 
subequal, (0.3)0.5–1.2(1.5) × 0.7–1(1.2) mm, ± deltate or ovate-triangular to 
triangular-lanceolate, acute or obtuse, sometimes sub-acuminate, rarely sub-truncate; 
in fruit greenish, usually drying purple-veined, (10)12–20(23) × (8)10–15(20) mm, 
globose to ± ovoid, 10-angled-ribbed or 10-ribbed, slightly obtuse or apiculate at the 
summit, half to almost filled by the fruit, subglabrous to pilose, mostly with long 
hairs especially along the ribs and nerves, often the ribs with widely spaced small 
teeth or enations derived from the hair bases, the lobes (0.5)1–2.5(3) × 1–2 mm. 
Calyx (1. 5)2–3.5(4) mm long, 1. 5–2.5(3) mm across at the base of the lobes, 
campanulate, sub-angled-ribbed, truncate or invaginated at the base, with scattered, 
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stout, white or hyaline, ± spreading, long hairs, or puberulous especially along the 
ribs, on the inside glabrous except for the lobes with ± dense, minute indumentum 
towards the apex, near the margins and sometimes also along the midribs; lobes 
subequal, (0.3)0.5–1. 2(1. 5) × 0.7–1(1. 2) mm, ± deltate or ovate-triangular to 
triangular-lanceolate, acute or obtuse, sometimes sub-acuminate, rarely sub-truncate; 
in fruit greenish, usually drying purple-veined, (10)12–20(23) × (8)10–15(20) mm, 
globose to ± ovoid, 10-angled-ribbed or 10-ribbed, slightly obtuse or apiculate at the 
summit, half to almost filled by the fruit, subglabrous to pilose, mostly with long 
hairs especially along the ribs and nerves, often the ribs with widely spaced small 
teeth or enations derived from the hair bases, the lobes (0.5)1–2.5(3) × 1–2 mm 
Corolla 
Corolla greenish-yellow or yellow to white or greenish-cream, slightly 
purplish marked or apparently unmarked, more rarely blotched with 5 ± dark purple 
to brown markings not strongly contrasting with the surrounding limb, (3)4–5(7) 
mm long, tubular-campanulate, often narrowly so; tube glabrous, on the inside with 
a few hyaline hairs from the insertion of the stamens upwards; limb (2)3–6 mm 
across, shortly 5-lobed, erect or spreading, rarely reflexed when fully expanded, 
glabrous or puberulous on the parts not folded in bud, glabrous inside, ciliate. 
Corolla greenish-yellow or yellow to white or greenish-cream, slightly purplish 
marked or apparently unmarked, more rarely blotched with 5 ± dark purple to brown 
markings not strongly contrasting with the surrounding limb, (3)4–5(7) mm long, 
tubular-campanulate, often narrowly so; tube glabrous, on the inside with a few 
hyaline hairs from the insertion of the stamens upwards; limb (2)3–6 mm across, 
shortly 5-lobed, erect or spreading, rarely reflexed when fully expanded, glabrous or 
puberulous on the parts not folded in bud, glabrous inside, ciliate 
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Stamens 
Stamens included or slightly exserted, equal or subequal; filaments (1)1.5–
3(3.5) mm long, filiform, attached to the corolla tube near the base, furnished with 
few hairs; anthers yellowish, sometimes blue-margined, 0.8–1 mm long, ± oblong or 
elliptic in outline, straight after anthesis. Stamens included or slightly exserted, 
equal or subequal; filaments (1)1. 5–3(3.5) mm long, filiform, attached to the corolla 
tube near the base, furnished with few hairs; anthers yellowish, sometimes blue-
margined, 0.8–1 mm long, ± oblong or elliptic in outline, straight after anthesis 
Disc 
Disk 0.2–0.3 mm high, fleshy, glabrous. Disk 0.2–0.3 mm high, fleshy, 
glabrous 
Pistil 
Ovary 0.8–0.9 × 0.6–0.7 mm, ellipsoid or ± globose, glabrous; style 2–3 mm 
long, filiform, ± curved upwards. 
Fruits 
 Fruit greenish-yellow or pale yellow, occasionally yellow, subsessile or with 
a gynobase up to 1 mm long on the invaginated base of the erect to pendulous calyx, 
(5)6–10 mm in diameter, ± globose or slightly ovoid, viscid. Fruit greenish-yellow 
or pale yellow, occasionally yellow, subsessile or with a gynobase up to 1 mm long 
on the invaginated base of the erect to pendulous calyx, (5)6–10 mm in diameter, ± 
globose or slightly ovoid, viscid 
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Seeds 
 Seeds light brown or yellowish, (1.5)1.8–2 × (1.5)1.6–1.8(2) mm, ovate to 
orbicular in outline, sometimes reniform, reticulate-foveolate. Seeds light brown or 
yellowish, (1. 5)1. 8–2 × (1. 5)1. 6–1. 8(2) mm, ovate to orbicular in outline, 
sometimes reniform, reticulate-foveolate 
Action and uses: 
It has been hypothesized that physalis extract affords protection by impairing 
CCl4 mediated lipid peroxidation, through decreased production of free radical 
derivatives. Which methanolic extract of Physalis minima leaves was investigated 
on ethanol induced ulcer models and pylorus ligation in wistar rats. The present 
study indicates that Physalis minima leaves extract have potential anti-ulcer activity 
in both models. This results may further suggests that methanolic extract was found 
to possess anti-ulcerogenic as well as ulcer healing property, which might be anti-
secretory activity. As Physalis in rich in Flavonoids it is having hepatoprotective 
effect studies suggest that the aqueous and ethanol extracts prepared from the whole 
plant of these species were evaluated for their antihepatoma activity. The results 
conclude that plant possesses potent antihepatoma activity and its effect on 
apoptosis is associated with mitochondrial dysfunction. Physalis lagascae roots 
extract has potent anti-asthmatic activity. Its anti-asthmatic property probably acts 
via a reduction in inflammatory mediator’s release. Thus the Physalis lagascae has 
significant anti-asthmatic property. 
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5. MATERIALS AND METHODS 
PLANT MATERIALS 
The aerial parts of Physalis lagascaewas collected from Tirunelveli district 
in September 2017 and authenticated by Dr.G.Johnsichristobel., Ph.D. Head of the 
Department & Research center, Department of Botany, Marthandam-629 165, 
Kanyakumari District.  A voucher specimen of Physalislagascae(JKKM/POC/CC-
285) was deposited in the department of pharmaceutical chemistry in JKKMMRF’S 
- Annai Sampoorani Ammal College of Pharmacy, Komarapalayam for future 
reference. The air dried aerial parts of the plant material was dried at room 
temperature, pulverized by a mechanical grinder, sieved through 40 mesh and then 
stored in an air tight and light resistant container for further use. 
PRELIMINARY PHYTOCHEMICAL STUDIES 
PREPARATION OF EXTRACT 
 About 1 kg of coarsely powdered plant material was first extracted with 
ethanol for 72 hours.  The extract was concentrated using rotary evaporator to get 
solid residue. The marc left was removed, dried .Then the solvent changed and again 
successively extracted with chloroform. Then the product was collected and the 
solvent again removed. Then it again extracted with the ethyl acetate. The product 
also collected and the solvent again changed with petroleum etheruntil complete 
extraction was effected for 72 hrs. The product collected separately subjected to 
distillation. The percentage yield of each extract was calculated on dry weight 
analysis 
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Fig. 8: Scheme of extraction of the aerial parts of Physalis lagascae 
1. Detection of carbohydrates and glycosides 
a)  Molish’s test 
To small amount of sample and water solution add 2, 3 drops of alcoholic 
alpha naphthol solution and 2ml of concentrated sulphuric acid solution through the 
side s of the test tube. The formation of brown to violet ring indicate the presence of 
the carbohydrate.  
b) Iodine test 
To the filtrate iodine solution was added. The formation of deep to purple 
colour indicate the presence of the starch 
c) Legal’s Test 
The filtrate was hydrolyzed with concentrated hydrochloric acid. To that add 
1ml of pyridine and few drops of sodium nitro prusside. Finally make the solution 
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alkaline by using sodium hydroxide. The formation of pink to red color indicate the 
presence of glycosides. 
d) Borntrager’s Test 
The filtrate was hydrolyzed with con.hydrochloric acid .it was added with 
chloroform and separates the chloroform layer and add equal volume of dilute 
ammonia solution. The ammonia layer acquired pink color indicate the presence of 
glycoside 
 2. Detection of alkaloids 
Small quantity of extract was treated withdil.hydrochloric acid and filtered it. 
The collection of filtrate was used for the following tests 
a) Mayer’s Test 
 To the filtrate potassium mercuric iodide was added .Cream precipitate 
indicate the presence of alkaloids 
b) Dragendroff’s Test 
To the filtrate potassium bismuth iodide was added .The formation of reddish 
brown precipitate indicate the presence of the alkaloids 
c) Wagner’s Test 
To the filtrate iodine and potassium iodide was added, Reddish brown 
precipitate indicate the presence of the alkaloids 
d) Hager’s Test 
The filtrate picric acid was added. The formation of yellow color precipitate 
indicate the presence of the alkaloids 
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3. Detection of phytosterols and steroids 
Small quantity of the sample dissolved in chloroform and subjected to the 
following tests  
a) Salkowsky Test 
To the above solution 1ml chloroform and few drops of concentrated 
sulphuric acid was added. The formation of the red color indicate the presence of the 
steroids 
b) Libermann Burchard Test 
To the above solution 1ml of chloroform and few drops of con.sulphuric acid 
and 1ml of acetic anhydride. The formation of green color indicate the presence of 
steroid. 
4. Detection of proteins and amino acids 
Small quantity of extract was added with water and filter it. 
a) Million’s Test 
To the above solution millions reagent was added. The formation of red 
color indicate the presence of proteins 
b) Biuret Test 
To the filtrate sodium hydroxide and copper sulphate solution added. Blue 
color indicate the presence of proteins, amino acid 
4. Detection of tannins 
a) To the 5ml of the extract 1ml of ferric chloride solution was added. The 
color change indicate the presence of tannins. 
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b) To the 5ml of the extract 1ml of aqueous potassium dichromate solution 
was added. The formation of blue color indicate the presence of tannins 
5. Detection of flavonoid 
a) To the extract sodium hydroxide was added. The formation of yellow 
color shows the presence of flavonoids 
b) To the extract con.sulphuric acid was added. Color change shows the 
formation of the flavonoids  
 c) Shinodas Test: To the small quantity of sample dissolved in alcohol and 
add magnesiummetal and con.hydrochloric acid. Magenta color indicate the 
presence of flavonoids 
d) Alkaline reagent test: To the extract sodium hydroxide solution was 
added it gives yellow color which shows the presence of flavonoids. 
6. Detection of fixed oils 
a) Spot Test: The small quantity of extract was pressed between two filter 
paper. The appearance of stain on the paper indicate presence of fixed oil 
b)To the extract few drops of alcoholic potassium hydroxide and 
phenolphthalein were added and heated the solution. The color change indicate the 
presence of fixed oils 
7. Detection of gums and mucilages 
a) To the extract 25ml of alcohol was added with stirring and filtered it 
.Then precipitate was dried. The formation of swelling indicate the presence of gums 
and mucilages. 
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8. Detection of saponins 
a) The extract was diluted with distilled water and it was agitated in a 
graduated cylinder for 15 minutes. The formation of form indicate the presence of 
saponins 
9. Detection of steroids 
a)  Libermann Burchard Test 
To the extract 1ml of the chloroform and con.sulphuric acid were added. 
Followedby acetic anhydride was added. Greenish color indicate the presence of 
steroid 
Table 1: Data showing the preliminary phytochemical screening of the extracts 
of Physalis lagascae 
Name of the 
Test 
Petroleum 
ether extract 
Chloroform 
extract 
Ethyl 
acetate 
extract 
Alcohol 
extract 
Carbohydrate - + + + 
Glycoside - - - - 
Protein + - + - 
Alkaloid + + + + 
Saponins - - - + 
Tannin + + - + 
Phytosterols 
and steroids 
+ + - + 
Flavonoids - - - - 
Fixed oil + + + + 
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6. CHROMATOGRAPHIC STUDIES 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
 Thin layer chromatography studies are among the key identity tests in most 
pharmacopoeial monographs. Pharmacopoeial standards are typically used by 
industry as a basis for meeting QC requirements and current good manufacturing 
practices (cGMPs). An extension of TLC is high-performance thin layer 
chromatography (HPTLC) is robust, simplest, rapid, and efficient tool in 
quantitative analysis of compounds. HPTLC is an analytical technique based on 
TLC, but with enhancements intended to increase the resolution of the compounds 
to be separated and to allow quantitative analysis of the compounds. Some of the 
enhancements such as the use of higher quality TLC plates with finer particle sizes 
in the stationary phase which allow better resolution. 
 The separation can be further improved by repeated development of the 
plate, using a multiple development device. As a consequence, HPTLC offers better 
resolution and lower Limit of Detection (LODs). Visual detection is suitable for 
qualitative analysis, but a more specific detection method is needed for quantitative 
analysis and for obtaining structural information on separated compounds. UV, 
diode-array and fluorescence spectroscopy, mass spectrometry (MS), Fourier-
transform infrared (FTIR), and Raman spectroscopy have all been applied for the in 
situ detection of analyte zones on a TLC plate.  
High-performance thin-layer chromatography (HPTLC) is a form of thin-
layer chromatography (TLC) that provides superior separation power using 
optimized coating material, novel procedures for mobile-phase feeding, layer 
conditioning, and improved sample application. It promotes for higher separation 
efficiencies, shorter analysis time, lower amounts of mobile phase, and efficient data 
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acquisition and processing. The major parameters that influence separation of the 
constituents within a mixture are the partition coefficients, retention factor (Rf), and 
capacity factor of the individual constituents on the plate, selectivity of the mobile 
and stationary phase to the solutes, and the plate height that decide the separation 
efficiency as well as resolution of the individual constituents within a mixture.  
 The partition coefficient is defined as the molar concentration of the analyte 
in the stationary phase to that in the mobile phase. Rf, a fundamental qualitative 
value, is expressed as the ratio of migration distances of an individual components 
of a mix relative to the mobile phase. Capacity factor (k) is a fundamental 
characteristic of a substance that determines its qualitative chromatographic 
behavior. It can be expressed as the ratio of the retention time of the substance in the 
stationary to that in the mobile phase and is influenced by the chemical nature of the 
two phases.  
 The separation number (SN) that influences separation power of HPLC is 
defined as the highest possible number of components that are completely separated 
in a mixture under a gradient-free isocratic TLC. The efficacy of separation of two 
components of a mixture in a chromatogram is termed as resolution and is 
influenced by the selectivity of the components between the stationary and the 
mobile phase, mobile phase flow rate influenced by particle size and solvent 
strength that influence capacity factors. 
 The usage of HPTLC is well appreciated and accepted all over the world. 
Many methods are being established to standardize the assay methods. HPTLC 
remains one step ahead when compared with other tools of chromatography. One of 
the available chromatographic techniques is HPTLC, which is used for the 
identification of constituents, identification and determination of impurities, and 
quantitative determination of active substances. The use of modern apparatus such 
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as video scanners, densitometers, and new chromatographic chambers, and more 
effective elution techniques, high-resolution sorbents with selected particle size or 
chemically modified surface, the possibility of combining with other instrumental 
methods, and development of computer programs for method optimization all make 
HPTLC an important alternative method to HPLC or gas chromatography. 
  Specifically, HPTLC is one of the ideal TLC technique for the analytical 
purposes because of its increased accuracy, reproducibility, and ability to document 
the results, compared with standard TLC. Because of this, HPTLC technologies are 
also the most appropriate TLC technique for conformity with GMPs. 
 HPTLC remains one of the most flexible, reliable, and cost-efficient 
separation technique ideally suited for the analysis of botanicals and herbal drugs. 
Used with standardized procedures, it guarantees reproducible results, a vital 
element in the routine identification of complex fingerprints of plant extracts and 
pharmaceutical products.It has established itself as the method of choice for 
handling complex analytical tasks involving herbal drugs and botanicals.  
 It has established itself as the method of choice for handling complex 
analytical tasks involving herbal drugs and botanicals. The unique combination of 
state-of-art instrumentation, standardized procedures, and solid theoretical 
foundations enables it to deliver reliable, cGMP-compliant results time after time. 
High-throughput analysis using HPLTC is being aimed at the rapid analysis of large 
numbers of compounds. This field has been expedited by the requirement to provide 
analytical support for multiple drug targets emerging from the field of molecular 
biology, human genetics, and functional genomics 
 HPTLC is one of the most widely applied methods for the analysis in 
pharmaceutical industries, clinical chemistry, forensic chemistry, biochemistry, 
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cosmetology, food and drug analysis, environmental analysis, and other areas. It is 
due to its numerous advantages, for example, it is the only chromatographic method 
offering the option of presenting the results as an image. Other advantages include 
simplicity, low costs, and parallel analysis of samples, high sample capacity, rapidly 
obtained results, and possibility of multiple detection. 
 The HPTLC technique is rapid, comparatively simple, robust, and extremely 
versatile. HPTLC not only confirm but also establish its identity. It is also an ideal 
screening tool for adulterations and is highly suitable for evaluation and monitoring 
of cultivation, harvesting, and extraction processes and testing of stability.  
 In recent years, HPTLC is a globally accepted practical solution to 
characterize small molecules in quality assessment throughout the developing world. 
HPTLC is used for purity control of chemicals, pesticides, steroids, and water 
analysis. HPTLC is also widely used for analysis of vitamins, water-soluble food 
dyes, pesticides in fruits, vegetables, and other food stuffs.Beate et al reported the 
analysis of stem cell lipids by offline HPTLC-MALDI-TOF MS. HPTLC is useful 
in detecting chemicals of forensic concern, including abuse drugs, poisons, 
adulterations, chemical weapons, and illicit drugs. 
Instrumentation 
                Injection of the sample: Septum injectors are available; using which sample 
solution is injected. Sample can be injected when the mobile phase is flowing or it is 
stopped. A new advanced rotary valve and loop injector can be used to produce 
reproducible results. The detector: There are several ways of detecting when a 
substance has passed through the column. Generally UV spectroscopy is attached, 
which detect the specific compounds. Many organic compounds absorb UV light of 
various wavelengths. The amount of light absorbed will depend on the amount of a 
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particular compound that is passing through the beam at the time. Interpreting the 
output from the detector: The output is recorded as a series of peaks, each one 
representing a compound in the mixture passing through the detector and absorbing 
UV light. The area under the peak is proportional to the amount of substance, which 
is passed through detector, and this area can be calculated automatically by the 
computer linked to the display. 
 
Fig. 9: Instrumentation  
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Fig. 10: HPTLC instrumentation 
HPTLC ANALYSIS 
 ETHANOL EXTRACT OF PHYSALIS LAGASCAE WITH GALLIC ACID 
AND QUERCETIN STANDARD  
Sample given 
Sample PL  –  Sample PL Ethanolic extract  
SG  -  Gallic acid standard as a reference marker 
SQ  -  Quercetin standard as a reference marker 
Procedure 
Test solution preparation 
The given plant sample was centrifuged at 3000rpm for 5min.  This solution 
was used as test solution for HPTLC analysis. 
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Sample application 
 1µl of test solution and 2 µl of standard solutions were loaded as 5mm band 
length in the 3 x 10 Silica gel 60F254 TLC plate using Hamilton syringe and 
CAMAG LINOMAT 5 instrument. 
Spot development 
 The sample loaded plate was kept in TLC twin trough developing chamber 
(after saturated with Solvent vapor) with respective mobile phase up to 90mm. 
Photo-documentation  
 The developed plate was dried by hot air to evaporate solvents from the 
plate.  The plate was kept in Photo-documentation chamber (CAMAG 
REPROSTAR 3) and captured the images at visible light, UV 254nm and 
UV366nm. 
Derivatization 
 The developed plate was sprayed with respective spray reagent and dried at 
100°C in Hot air oven.  The plate was photo-documented in Visible light mode 
using Photo-documentation (CAMAG REPROSTAR 3) chamber. 
Scanning 
 Before derivatization, the plate was fixed in scanner stage (CAMAG TLC 
SCANNER 3) and scanning was done at UV 366nm.  The Peak table, Peak display 
and Peak densitogram were noted.  The software used was win CATS 1.3.4 version. 
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ANALYSIS DETAILS 
Mobile phase 
 100% Chloroform  
Spray reagent 
Anisaldehyde sulphuric acid reagent.  
Detection  
Yellowish orange coloured zone at Visible mode/ Blue color fluorescent 
zone in UV 366nm mode was present in thetrack, it was observed from the 
chromatogram after derivatization, which maybe the Presence of Quercetin in the 
given standard. 
Gallic acid standard was not moved from the loading point for the given 
mobile phase. 
Peak table 
Track Peak Rf Height Area Assigned substance 
Sample PL 1 0.14 84.1 1356.3 Unknown 
Sample PL 2 0.88 32.1 914.3 Unknown 
Sample PL 3 0.92 45.6 1369.3 Unknown 
SQ 1 16.6 22.93 147.4 Quercetin standard 
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Chromatogram 
 
Before derivatization                                                                               
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After derivatization 
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Track 1 – Sample PL plant extract sample- Baseline display  
(Scanned at 366 nm) 
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Track 1 – Sample PL plant extract sample - Peak densitogram display  
(Scanned at 366 nm) 
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Track STD –Gallic acid standard Baseline display  
(Scanned at 366 nm) 
 
 
 
 
 
 
 Chapter  6  Chromatographic Studies 
 
Dept. of Pharmaceutical Chemistry  73  JKKMMRF College of Pharmacy 
 
Track STD – Gallic acid standard Peak densitogram display  
(Scanned at 366nm) 
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Track STD –Quercetin standard Baseline display  
(Scanned at 366 nm) 
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Track STD – Quercetin standard Peak densitogram display  
(Scanned at 366nm) 
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3D display of all Tracks 
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NOTE 
Sample PL  –  Sample PL Ethanolic extract  
SG  -  Gallic acid standard as a reference marker 
SQ  -  Quercetin standard as a reference marker 
Here we used the Ethanolic extract of Physalis lagascaefor the HPTLC. The 
garlic acid standard and Quercetine standard as a reference marker. The movement 
of the sample was comparedwith the other two components and finally decide the 
presence of compound  
Yellowish orange coloured zone at Visible mode/ Blue color fluorescent 
zone in UV 366nm mode was present in thetrack, it was observed from the 
chromatogram after derivatization, which maybe the Presence of Quercetin in the 
given standard. 
 Gallic acid standard was not moved from the loading point for the given 
mobile phase. 
 Quercetin, a plant flavonol from the flavonoid group of polyphenols, is 
found in many fruits, vegetables, leaves, and grains; red onions and kale are 
common foods containing appreciable content of quercetin.It has a bitter flavor and 
is used as an ingredient in dietary supplements, beverages, and foods. Quercetin is 
a flavonoid widely distributed in nature.[2] The name has been used since 1857, and 
is derived from quercetum (oak forest), after Quercus. It is a naturally 
occurring polar auxin transport inhibitor. In plants, phenylalanine is converted to 4-
coumaroyl-CoA in a series of steps known as the general phenylpropanoid pathway 
using phenylalanine ammonia-lyase, cinnamate-4-hydroxylase, and 4-coumaroyl-
CoA-ligase. One molecule of 4-coumaroyl-CoA is added to three molecules 
of malonyl-CoA to form tetrahydroxychalcone using 7, 2′-dihydroxy-4′-
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methoxyisoflavanol synthase. Tetrahydroxychalcone is then converted 
into naringenin using chalcone isomerase. 
Naringenin is converted into eriodictyol using flavonoid 3′-hydroxylase. 
Eriodictyol is then converted into dihydroquercetin with flavanone 3-hydroxylase, 
which is then converted into quercetin using flavonol synthase. 
 Quercetin is the aglycone for of a number of other flavonoid glycosides, such 
as rutin and quercitrin, found in citrus fruit, buckwheat and onions. Quercetin forms 
the glycosidesquercitrin and rutin together with rhamnoseand rutinose, respectively. 
Likewise guaijaverinis the 3-O-arabinoside, hyperoside is the 3-O-
galactoside, isoquercitin is the 3-O-glucosideand spiraeoside is the 4′-O-
glucoside. CTN-986 is a quercetin derivative found in cottonseeds and cottonseed 
oil. Miquelianin is the quercetin 3-O-β-D-glucuronopyranoside. 
In vitro pharmacology 
Quercetin has been reported to inhibit the oxidation of other molecules and 
hence is classified as an antioxidant.Quercetin contains a polyphenolic chemical 
substructure that stops oxidation by acting as a scavenger of free radicals that are 
responsible for oxidative chain reactions Quercetin also activates or inhibits the 
activities of a number of proteins. For example, quercetin is a non-specific protein 
kinase enzyme inhibitor. Quercetin has also been reported to 
have estrogenic (female sex hormone-like) activities by activating estrogen 
receptors. Quercetin activates both estrogen receptor alpha (ERα) 
and beta (ERβ) with binding IC50 values of 1015 nM and 113 nM, respectively. 
Hence quercetin is somewhat ERβ selective (9 fold) and is roughly two to three 
orders of magnitude less potent than the endogenous estrogenic hormone 17β-
estradiol.In human breast cancer cell lines, quercetin has also been found to act as 
an agonist of the G protein-coupled estrogen receptor (GPER).(39) 
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7. PHARMACOLOGICAL SCREENING 
Invitro Anticancer Mechanism of Plant Compounds 
 Carcinogenesis is due to the presence of toxic chemicals, excessive use of 
alcohol, exposure to excessive sunlight and environmental toxins, some poisonous 
mushrooms, inherent genetic problems, ionizing radiation and several viruses. 
Angiogenesis, invasiveness and metastasis are the regular expression of progressive 
phase of the malignant disease. Treatment of cancer in developed countries is given 
by the combination of surgery, chemotherapy and radiation. This sort of treatment 
destroys the protective mechanism of cancerous cells and its metastasis but their 
toxic effect kills normal cells along with cancer cells. It decreases the hematological 
level and immune disorder making the patient liable to infections. Cytotoxicity 
screening test is the preliminary method for assortment of active plant extracts 
against cancer. Therapeutic value of medicinal plants is chiefly because of the 
presence of alkaloids and polyphenols, thus they are much concentrated than other 
secondary metabolites available in the plants. The cytotoxicity and genotoxicity of 
medicinal plants in terms of herbal extracts, infusions, essential oils and fractions is 
evaluated using cytogenic assays for their mutagenic and carcinogenic effects. The 
search for safety tools for the treatment of malignancy resulted in identifying plants 
and its compounds with properties like herbal adaptogen, anti-stress and 
immunomodulators. However many people still use traditional medicine as an 
alternative treatment for cancer. (45) 
Current scenario of degenerative disease:  
In spite of modern developments in prevention, diagnosis and therapy, 
cancer stays as a vast threat to human health and affects millions of people 
worldwide. In developing countries the cervical cancer (gynecological malignant 
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tumour) commonly causes harm to women health. Although the chemical 
components and mechanism of action of natural plants with anti-cervical cancer 
potential have been discussed, many others remain unknown. At present, breast 
cancer is the crucial cause of cancer-related death in women worldwide, although 
radiation and chemotherapy are accessible, they enclose loads of lethal and long-
term side effects and even some of them are stable which can cause infertility. 
Malignant and aggressive ER (estrogen receptor) negative breast cancer is resistant 
to hormonal therapy.  
 Myelo-suppression and anemia are the two major problems encountered in 
chemotherapy as the result of reduction in erythrocytes or hemoglobin which has 
occurred due to iron deficiency/ hemolytic/ myelopathic conditions. Hematological 
toxicity of drugs triggers higher possibility of neutropenia with thrombocytopenia. 
Liver functions are commonly impaired among cancer patients who lead to the loss 
of functional integrity of the cell membrane resulting in elevated levels of aspartate 
and alanine amino transferase, alkaline phosphatase and serum bilirubin. Chemo-
preventive agents of plant's origin react by producing nitrosoamines which inhibit 
carcinogen formation, as blocking agents that avert carcinogens from reacting or 
reaching to target sites and thus act as suppressing or anti-proliferative agents. 
Arginine functions as an essential substrate for the anti-tumour immune system 
especially T-lymphocytes. Nitric oxide (NO) may prevent malignant outgrow by 
activating tumour suppressor genes and causing apoptosis91. However, 
malignancies revert these anti-tumour mechanisms by interfering with arginine/NO 
metabolism by inducing myeloid derived suppressor cells (MDSC) that produce the 
arginine converting enzymes arginase and inducible nitric oxide synthase (iNOS). 
This may contribute to malignant outgrow and development of cancer associated 
opportunistic syndromes (cancer cachexia). Now, the major criteria for treatment are 
metabolic failure in cancer patients and multidrug resistance- associated protein 
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(MRP1/ABCC1). Accordingly the curiosity is rising in the identification of naturally 
occurring molecules with chemo-preventive and chemotherapeutic properties. (23) 
Carcinogenesis and Chemoprevention:  
Free radicals are generated in living systems as part of metabolic activities 
and their levels are regulated by cellular antioxidant system. Uncontrolled levels of 
reactive oxygen species (ROS) can cause cell membrane damage and DNA mutation 
which further results in development of many diseases such as cancer, brain 
disorders and cardiovascular diseases. Free radicals react with purines, pyrimidines 
and chromatin protein (cellular biomolecules) leading to base modifications, 
unstable genomes and genetic alterations. ROS generation alters the activity of many 
early response genes and transcription factors66. Plant polyphenols act on multiple 
cancer-inflammation and reactive oxygen/reactive nitrogen species (ROS/RNS)-
mediated pathways that inhibit oxidative stress and DNA damage that is implicated 
in mutagenesis, carcinogenesis and premature ageing. Oxidative stress can be 
premodulated with the interference of exogenous antioxidants like curcumin, 
resveratrol, catechin and gensitein. Consumption of diet containing high portion of 
vitamins has confirmed advantageous in cancer prevention.  
Occurrence of Secondary cancer:  
High morbidity and mortality rates among the cancer patients are due to the 
presence of advanced stages of cancer cells having highly invasive potential. 
Inhibition of invasion and metastasis may be and invasiveness to cancer cells during 
tumour distribution. Matrix metalloproteinases (MMPs), a family of Zn dependent 
endopeptidases have a central functional role in tumour cell migration, spreading, 
invasion and metastasis. Reversion- inducing cysteine- rich protein with kazal 
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motifs (RECK) acts as a negative regulator of MMPs a good approach to cancer 
treatment. Epithelial mesenchymal transition (EMT) provides greater motility (33) 
Invasion:  
Solanum nigrum Linn. Consists of steroidal glycoalkaloid, α-solanine which 
increases the expression of epithelial marker Ecadherin and decreases the expression 
of mesenchymal marker vimentin and therefore it suppresses epithelial 
mesenchymal transition (EMT). The glycoalkaloid, α-solanine reduces the mRNA 
level of matrix metalloproteinase2 (MMP2), MMP9 and extracellular matrix 
metalloproteinase inducer (EMMPRIN) but increases the expression of RECK and 
TIMP-1 and 2 (tissue inhibitors of metalloproteinases). It also suppresses the 
phosphorylation of phosphatidylinositide 3 kinase (PI3K), Akt (protein kinase B) 
and ERK (extracellular signal-regulated kinases). Thus α-solanine down regulates 
oncogenic microRNA21 (miR-21) and upregulates tumour suppressor miR138 
expression to suppress the invasion of prostate cancer cell. 
Metastasis:  
Cancer occurs when the cells gets damaged at nucleic acid level in a 
progressive way resulting in cancer stem cells that possess a malignant phenotype. 
Malignant tumour cells are considered to have the capacity to metastasize. Early 
breast cancer becomes metastatic after many years of its occurrence. Metastasis is 
the foremost reason of mortality among cancer patients. When the tumour cells have 
come to respite in another site, they enter the vessel walls, continue to multiply and 
ultimately form another tumour. MMPs are significant in tumourigenesis and 
metastasis. They cleave the extracellular matrix (ECM) substrates. Degradation of 
ECM is a key event in tumour progression, invasion and metastasis26. MMP-2 and -
9 are important molecules for cancer invasion highly expressed in bladder and colon 
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cancer cells.23, 156 TIMPs are naturally occurring inhibitors of MMPs which 
prevent catalytic activity by binding to activated MMP62. Spontaneous and 
experimental metastasis to the liver is increased in mice expressing antisense TIMP-
176. (43) 
Indigenous treatment:  
More than 60% of cancer patients use vitamins or herbs as therapy65. In 
traditional folk medicine, Curcuma longa L. (turmeric) is used for centuries as 
cancer treating medicine. Curcumin (or diferuloylmethane) suppress mutagenesis, 
inhibits nuclear factor- kB (NF-kB) activation, suppression of cyclin D1, induction 
of cytochrome C release, activation of caspases and also has anti-angiogenic effects 
through the down regulation of VEGF (Vascular Endothelial Growth Factor) 1. 
Allicin, a compound isolated from Allium sativum L. inhibits the activation of 
procarcinogens. Murraya koenigii L. leaves rich in polyphenols inhibit the 
proteolytic activity of the cancer cell proteasome and cause cell death122. It shows 
strong cytotoxicity against oral cavity cancer (KB), breast cancer (MCF7) and small 
cell lung cancer (NCI-H187) human cell lines. Series of medicinal plants were used 
specifically and constantly in traditional medicine is because of their spectrum of 
pharmacological activities related with the biologically active chemicals. (20) 
Traditional plants:  
A global broad-spectrum thought of medicinal plant users are ―the drugs 
derived from plants are always safe because they are natural‖. Plants are generally 
used in Ayurvedic medicinal practices to promote self-healing, good health and 
longevity. However, numerous scientific evidences had revealed that many plants 
are included as food or drug in traditional medicine.. Mostly previous works were 
focused on plant compounds like curcumin, β - carotene, stigmasterol, lupeol, 
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ursolic acid and β - sitosterol. Over exploitation of particular group of plants will 
cause problems in diversity and possible extinction. Other plants are preferable, as 
they may have novel potent compounds with therapeutic targets such as anti-
mutagenic, anti-carcinogenic, anti- angiogenesis, anti- invasive, anti- metastasis, 
anti- proliferation, anti- inflammatory and apoptotic activity. 
The International Agency for Research on Cancer estimates of the incidence 
of mortality and prevalence from major types of cancer, at national level, for 184 
countries of the world revealed that there were 14.1 million new cancer cases, 8.2 
million cancer deaths, and 32.6 million people living with cancer (within 5 years of 
diagnosis) in 2012 worldwide [1]. By 2030, it is projected that there will be 26 
million new cancer cases and 17 million cancer deaths per year. 
 Today, despite considerable efforts, cancer still remains an aggressive killer 
worldwide. Moreover, during the last decade, novel synthetic chemotherapeutic 
agents currently in use clinically have not succeeded in fulfilling expectations 
despite the considerable cost of their development. 
 Therefore there is a constant demand to develop new, effective, and 
affordable anticancer drugs. From the dawn of ancient medicine, chemical 
compounds derived from plants have been used to treat human diseases. Natural 
products have received increasing attention over the past 30 years for their potential 
as novel cancer preventive and therapeutic agents. In parallel, there is increasing 
evidence for the potential of plant-derived compounds as inhibitors of various stages 
of tumorigenesis and associated inflammatory processes, underlining the importance 
of these products in cancer prevention and therapy. (49) 
 Approximately 60% of drugs currently used for cancer treatment have been 
isolated from natural products and the plant kingdom has been the most significant 
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source. These include vinca alkaloids, Taxus terpenes, Camptotheca alkaloids, 
and Podophyllum lignans. Currently, of 16 new plant-derived compounds being 
tested in clinical trials, 13 are in phase I or II and three are in phase III. Among these 
compounds, flavopiridol, isolated from the Indian treeDysoxylum binectariferum, 
and meisoindigo, isolated from the Chinese plant Indigofera tinctoria, have been 
shown to exhibit anticancer effects with lesser toxicity than conventional drugs. 
Medicinal plants constitute a common alternative for cancer treatment in many 
countries around the world. At this time, more than 3000 plants worldwide have 
been reported to have anticancer properties. Globally, the incidence of plant-derived 
products for cancer treatment is from 10% to 40% with this rate reaching 50% in 
Asiatic patients In Europe alone expenditure for anticancer herbal products is 
estimated to be 5 billion dollars per year  
 Israel, with its diverse climatic and geographic conditions, is home to some 
2400 plant species Situated in a transition zone between Mediterranean woodlands 
in the north, shrubby formations and herbaceous vegetation in the east and south, 
shrub-steppes and extreme desert areas in the southern Negev, and tropical 
vegetation in the hottest parts of the country, Israel possesses a great diversity of 
species many of which are endemic only to this area. With a long history of 
traditional use spanning many centuries, the medicinal plants of Israel present a 
unique opportunity for focused screening based on their ethnobotanical use. (30) 
 In the current study we initially examined the effects of 17 whole plant 
extracts (ethanol extraction) of Israeli plants on human tumor cell lines as well as 
human primary cancer cultures. The three most effective plant extracts were then 
selected for additional research focusing also on the nature of cell death caused by 
these plant extracts. Our hypothesis was that whole cell extracts might contain 
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multiple molecules with antitumor activities and be very effective in killing human 
cancer cells. 
 The 3 plant extracts investigated were Urtica membranacea (Urticaceae) 
(referred to as extract number 5 in the study), Artemesia monosperma (Asteraceae) 
(referred to as extract number 10), and Origanum dayi Post (Labiatae). 
 All plants were investigated as part of the Middle Eastern Medicinal Plant 
Project (MEMP), an initiative of The Natural Medicine Research Centre (NMRC) 
dedicated to the ethnobotanical investigation, domestication, conservation, and 
reintroduction and focused screening of Israeli medicinal flora  
 All three selected plant extracts exhibited dose- and time-dependent killing 
capabilities in various human derived haematological and solid tumor cell lines and 
in primary cultures established from patients’ biopsies. The killing activity was 
specific toward tumor cells, as the extracts had no effect on primary cultures of 
healthy human cells (lymphocytes and fibroblasts). Several experiments were 
carried out to characterize the plant extracts’ activities. Using various methods it 
was found that, using whole plant extracts, cell death was caused via apoptosis.(48) 
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8. INVITRO ANTI-CANCER ACTIVITY 
MTT Assay 
 Quantification of cell viability and proliferation form the fundamental for 
numerous in vitro assays in response to external factors. An MTT assay is a 
colorimetric assay based on assessing the cell metabolic activity. A549 Lung 
adenocarcinoma cell line was used to see the cytotoxic potential of a new drug for 
initial screening of apoptosis or necrosis. The biochemical mechanism behind the 
MTT assay involves NAD(P)H-dependent cellular oxidoreductase enzyme that 
converts the yellow tetrazolium MTT [3-(4, 5- dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide] into insoluble (E,Z)-5-(4,5-dimethylthiazol-2-yl)- 1,3-
diphenylformazan (formazan). The formed formazan can be dissolved with dimethyl 
sulfoxide (DMSO) to give a purple color with characteristic absorption at 540 nm. 
Intensity of purple color is directly proportional to the cell number and thus 
indicating the cell viability.  
When a new drug, either natural source or synthesize, is under investigation 
needs to examine its safety to the host cell or the cytotoxic effect in cancer cell. This 
is well-known as the cell viability test. This viability cell test may vary from the 
simple one to the completed one. For example, exposure of cell to trypan blue can 
be useful to identify the viable cell (unstained) using a microscope. Dead cell is not 
stained with trypan blue (Strober, 2001).  
This method is based on the cell membrane permeability. However, trypan 
blue staining cannot be used to distinguish between the healthy cells and the cells 
that are alive but losing cell functions. Another common method of examining the 
cell viability is the estimation of lactate dehydrogenase (LDH) level. LDH is present 
within the cytoplasm. When the integrity of a cell membrane is lost, then the 
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cytoplasmic LDH comes out of the cell, the LDH concentration in the extracellular 
medium is increased. This method is less sensitive than the MTT assay (Fotakis and 
Timbrell, 2006). Other methods used for the assessment of cell viability based on 
various cellular functions such as enzyme activity, cell membrane permeability, cell 
adherence, ATP production, co-enzyme production, and nucleotide uptake activity.  
Among them tetrazolium (MTT) is one of the most frequently methods. This 
method uses colorimeter to determine the cell viability (Mosmann et al., 1983). The 
MTT reagent yields low background absorbance values in the absence of cells. In 
MTT assay, the linear relationship between metabolically active cells and the color 
produced is established, thus allowing an accurate quantification of changes in the 
rate of cell death or proliferation (van de Loosdrecht et al., 1994). MTT is the 
commonly applied method for evaluation of cell viability and cytotoxicity for 
screening the drugs. The MTT assay based on the reduction of MTT (yellow 
colored) and other tetrazolium dyes depends upon cellular metabolic activities due 
to NAD(P)H-dependent cellular oxidoreductase enzymes (Berridge et al., 2005).  
 The healthy and rapidly growing cells exhibit high rates of MTT reduction to 
formazan while the dead or inactive cells fail to do so. The final product of MTT 
reduction is a purple color formazan that can be easily dissolved in DMSO. Viability 
in the MTT assay is connected with the quantification of formazan at 540 nm which 
is linearly associated with the enzyme activity and indirectly the number of viable 
cells. High purple color intensity denotes higher cell viability while the decrease in 
purple color intensity signifies the reduced cell number and thus cytotoxicity of the 
given substance 
The MTT assay is a colorimetric assay for assessing cell metabolic activity. 
NAD (P) H-dependent cellular oxidoreductase enzymes may, under defined 
conditions, reflect the number of viable cells present. These enzymes are capable of 
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reducing the tetrazolium dye MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide to its insoluble formazan, which has a purple color. 
Other closely related tetrazolium dyes including XTT, MTS and the WSTs, are used 
in conjunction with the intermediate electron acceptor, 1-methoxy phenazine 
methosulfate (PMS). With WST-1, which is cell-impermeable, reduction occurs 
outside the cell via plasma membrane electron transport.Tetrazolium dye assays can 
also be used to measure cytotoxicity (loss of viable cells) or cytostatic activity (shift 
from proliferation to quiescence) of potential medicinal agents and toxic materials. 
MTT assays are usually done in the dark since the MTT reagent is sensitive to 
light.(44) 
 MTT, a yellow tetrazole, is reduced to purple formazan in living cells.A 
solubilization solution (usually either dimethyl sulfoxide, an acidified ethanol 
solution, or a solution of the detergentsodium dodecyl sulfate in diluted hydrochloric 
acid) is added to dissolve the insoluble purple formazan product into a colored 
solution. The absorbance of this colored solution can be quantified by measuring at a 
certain wavelength (usually between 500 and 600 nm) by a spectrophotometer. The 
degree of light absorption depends on the solvent. 
 XTT (2, 3 - bis - (2 – methoxy – 4 – nitro – 5 - sulfophenyl) - 2H –
tetrazolium -5-carboxanilide) has been proposed to replace MTT, yielding higher 
sensitivity and a higher dynamic range. The formed formazan dye is water-soluble, 
avoiding a final solubilization step. 
 Water-soluble tetrazolium salts are more recent alternatives to MTT: they 
were developed by introducing positive or negative charges and hydroxy groups to 
the phenyl ring of the tetrazolium salt, or better with sulfonate groups added directly 
or indirectly to the phenyl ring. 
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 MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium), in the presence of phenazine methosulfate (PMS), 
produces a formazan product that has an absorbance maximum at 490 nm in 
phosphate-buffered saline. The MTS assay is often described as a 'one-step' MTT 
assay, which offers the convenience of adding the reagent straight to the cell culture 
without the intermittent steps required in the MTT assay. However this convenience 
makes the MTS assay susceptible to colormetric interference as the intermittent 
steps in the MTT assay remove traces of coloured compounds, whilst these remain 
in the microtitre plate in the one-step MTS assay. Precautions are needed to ensure 
accuracy when using this assay and there are strong arguments for confirming MTS 
results using qualitative observations under a microscope. (This, however, is prudent 
for all colormetric assays.)(28) 
 WSTs (water-soluble tetrazolium salts) are a series of other water-soluble 
dyes for MTT assays, developed to give different absorption spectra of the formed 
formazans.WST-1 and in particular WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium), are advantageous over MTT in 
that they are reduced outside cells, combined with PMS electron mediator, and yield 
a water-soluble formazan. Finally, WST assays (1) can be read directly (unlike MTT 
that needs a solubilization step), (2) give a more effective signal than MTT, and 3) 
decrease toxicity to cells (unlike cell-permeable MTT, and its insoluble formazan 
that accumulate inside cells)(29) 
PREPARATION OF REAGENTS 
  MTT stock solution: Dissolve 500 mg MTT powder in 10 mL phosphate 
buffer solution. Stir the solution with a magnetic stirrer for about 1 hour in the dark. 
Filter the sterilized solution with a 0.22 mm filter (Millipore, Ireland) and then store 
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it in 10-mL aliquots (50 mg/mL) at -20°C (van Merlo et al., 2011). The working 
solution (5 mg/mL) will be prepared on the day of experiment by dilution.  
1. Cells were seeded in a 96-well flat-bottom microtiter plate at a density of 1 × 
104 cells/well and allowed to adhere for 24 hours at 37°C in a CO2 
incubator. 
2. After 24 hours of incubation, culture medium was replaced with a fresh 
medium.  
3. Cells were then treated with various concentrations of the desired compound 
for 24 hours at 37°C in a CO2 incubator.  
4. After 24 hours of incubation, culture medium was replaced with a fresh 
medium. 
5. Subsequently, 10 μL of MTT working solution (5 mg/mL in phosphate 
buffer solution) was added to each well and the plate was incubated for 4 
hours at 37°C in a CO2 incubator. 
6. The medium was then aspirated, and the formed formazan crystals were 
solubilized by adding 50 μL of DMSO per well for 30 min at 37°C in a CO2 
incubator. 
7. Finally, the intensity of the dissolved formazan crystals (purple color) was 
quantified using the ELISA plate reader at 540 nm.  
General procedure:  
3[4, 5-dimethylthiazol-2-yl] 2, 5-diphenyltetrazolium bromide (MTT) is a 
yellow water soluble tetrazolium salt. A mitochondrial enzyme in living cells, 
succinate-dehydrogenase, cleaves the tetrazolium ring, converting the MTT to an 
insoluble purple formazan. Therefore, the amount of formazan produced is directly 
proportional to the number of viable cells 
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After 48 h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered saline (PBS) 
was added to each well and incubated at 370c for 4 hr. The medium with MTT was 
then discarded and the formed formazan crystals were solubilized in 100µl of 
DMSO and then measured the absorbance at 570 nm using micro plate reader. The 
percentage cell viability was then calculated with respect to control as follows 
                  % cell viability= [A] Test / [A] control×100 
Group I Cells Alone 1.352 0.812 1.105 1.089 100% 
Group II 
Cells + 
Etoposide 
0.827 0.767 0.760 0.784 28% 
Group III 
Cells + sample A 
(500mg/ml) 
0.414 0.469 0.436 0.439 59.6% 
 
Note:   
 Sample: Sample A 
 Etoposide used as a standard drug 
 Group I as Control (ie, Cells alone) 
. 
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Fig. 11 : Cell line image: A 549 (Lung cancer) 
The MTT assay was done and Etoposide used as the standard drug. The 
above table shows the result of the study. . The MTT assay is a colorimetric assay 
for assessing cell metabolic activity. NAD (P) H-dependent cellular oxidoreductase 
enzymes may, under defined conditions, reflect the number of viable cells present. . 
MTT assays are usually done in the dark since the MTT reagent is sensitive to light. 
Here we are using etoposide as the standard drug and the result compared with the 
cell with sample result. The assay result of cell with the standard drug etoposide 
shows 28% here, the standard shows 28% and the sample shows 59% there is a great 
difference between the results. The alcoholic extract of Physalis lagascae has anti-
cancer activity but its less when compared to the standard drug etoposide 
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9. RESULT AND DISCUSSION 
The result of present study, the qualitative analysis of ethanolic extract of 
Physalis lagascae showed the presence of carbohydrates, alkaloids, saponins, 
tannins, phytosterols and steroids and flavonoids. The effect of alcoholic extract of 
Physalis lagascae for its anti-cancer activity is tested by theMTT assay. The MTT 
assay is a colorimetric assay for assessing cell metabolic activity. NAD (P) H-
dependent cellular oxidoreductase enzymes may, under defined conditions, reflect 
the number of viable cells present. . MTT assays are usually done in the dark since 
the MTT reagent is sensitive to light. Here we are using etoposide as the standard 
drug and the result compared with the cell with sample result. The assay result of 
cell with the standard drug etoposide shows 28% here, the standard shows 28% and 
the sample shows 59% there is a great difference between the results. The alcoholic 
extract of Physalis lagascae has anti-cancer activity but it’s less when compared to 
the standard drug etoposide 
When we come to the chromatographic studies.Here we used the Ethanolic 
extract of Physalis lagascaefor the HPTLC. The garlic acid standard and Quercetine 
standard as a reference marker. The movement of the sample was compared with the 
other two components and finally decide the presence of compound  
Yellowish orange coloured zone at Visible mode/ Blue color fluorescent 
zone in UV 366nm mode was present in thetrack, it was observed from the 
chromatogram after derivatization, which maybe the Presence of Quercetinin the 
given standard. 
Gallic acid standard was not moved from the loading point for the given 
mobile phase. 
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Quercetin, a plant flavonol from the flavonoid group of polyphenols, is 
found in many fruits, vegetables, leaves, and grains; red onions and kale are 
common foods containing appreciable content of quercetin. It has a bitter flavor and 
is used as an ingredient in dietary supplements, beverages, and foods. Quercetin is a 
flavonoid widely distributed in nature.[2] The name has been used since 1857, and is 
derived from quercetum (oak forest), after Quercus. It is a naturally occurring polar 
auxin transport inhibitor. In plants, phenylalanine is converted to 4-coumaroyl-CoA 
in a series of steps known as the general phenylpropanoid pathway using 
phenylalanine ammonia-lyase, cinnamate-4-hydroxylase, and 4-coumaroyl-CoA-
ligase. One molecule of 4-coumaroyl-CoA is added to three molecules of malonyl-
CoA to form tetrahydroxychalcone using 7, 2′-dihydroxy-4′-methoxyisoflavanol 
synthase. Tetrahydroxychalcone is then converted into naringenin using chalcone 
isomerase. 
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10. CONCLUSION 
The result of the shows the presence of compounds like carbohydrates, 
alkaloids, saponins, tannins, phytosterols and steroids and flavonoids. The MTT 
assay and the Chromatographic studies give more information about the drug. When 
we go through the MTT assay it showed that the ethanolic extract of Physalis 
lagascae showed the in vitro anti-cancer activity but it’s very less when we compare 
it to the standard drug like the etoposide. The cell with standard drug etoposide 
showed 28% and the cell with sample showed 59.6%.The results can be analyzed as 
the cell with sample showed value higher than the cell with standard drug produced. 
The MTT assay gives clear idea about the in vitro anticancer activity of the plant 
extract. 
 The chromatographic study showed that the presence of the compound 
Quercetine which belongs to the group of flavonoids in the ethanolic extract of the 
plant Physalis lagascae. The chromatographic study showed that the standard 
reference marker Quercetine just moved from the initial point and the garlic acid 
extract didn’t show any movement from the initial point. This said that the sample 
contain Quercetine which belongs to the flavonoid group. The importance of 
flavonoid is it has the property of anti-oxidant, which is very helpful in the 
mechanism of anti-cancer activity.so, we can say that the extract of plant Physalis 
lagascae shows the anti-cancer activity 
 When we analyze both the result the MTT assay shows the plant extract of 
Physalis lagascaehas anti-cancer action .and the chromatographic study shows that 
the extract contain Quercetine which belongs to the group of flavonoids which 
having the property of anti-oxidant action which support the anti-cancer action of 
the plant 
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  97  JKKMMRF College of Pharmacy 
11. REFERENCES 
1. Abe, F., Nagafuji, S., Okawa, M. & Kinjo, J., 2006. Trypanocidal 
constituents in plants 6: minor withanolides from the aerial parts of Physalis 
angulata. Chemical and Pharmaceutical Bulletin 54(8): 1226–1228.  
2. Adjanohoun, E.J., Adjakidjè, V., Ahyi, M.R.A., Aké Assi, L., Akoègninou, 
A.,d’Almeida, J., Apovo, F., Boukef, K., Chadare, M., Cusset, G., Dramane, 
K.,  
3. Agati G, Azzarello E, Pollastri S, Tattini M. Flavonoids as antioxidants in 
plants: Location and functional significance. Plant Science. 2012; 196:67–76 
4. Akoègninou, A., van der Burg, W.J. & van der Maesen, L.J.G. (Editors), 
2006. Flore analytique du Bénin. Backhuys Publishers, Leiden, Netherlands. 
1034 pp.  
5. Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R. Overview of Major 
Classes of Plant-Derived Anticancer Drugs. International Journal of 
Biomedical Science. 2009; 5(1):1–11.  
6. Amos LA, Löwe J. How Taxol® stabilises microtubule structure. Chemistry 
& Biology. 1999; 6(3):65–69.  
7. Anonymous.The Wealth of India (Raw materials).CSIR, New Delhi; 1953, 
Vol.3: 97-99 
8. Burkill, H.M., 2000. The useful plants of West Tropical Africa. 2nd Edition. 
Volume 5, Families S–Z, Addenda. Royal Botanic Gardens, Kew, Richmond, 
United Kingdom. 686 pp.  
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  98  JKKMMRF College of Pharmacy 
9. Cancer Research UK [Accessed 23 January 2015]; World cancer 
statistics. 2014 Available at:http://www.cancerresearchuk.org/cancer-
info/cancerstats/world/ 
10. Chiang, H.C., Jaw, S.M.  & Chen, P.M., 1992. Inhibitory effects of physalin 
B and physalin F on various human leukemia cells in vitro. Anticancer 
Research 12(4): 1155–1162.  
11. Chiang, H.C., Jaw, S.M.  & Chen, P.M., 1992. Inhibitory effects of physalin 
B and physalin F on various human leukemia cells in vitro. Anticancer 
Research 12(4): 1155–1162.  
12. Chiang, H.C., Jaw, S.M., Chen, C.F. & Kan, W.S., 1992. Antitumor agent, 
physalin F from Physalis angulata L. Anticancer Research 12(3): 837–843.  
13. Costa-Lotufo LV, Khan MTH, Ather A, Wilke DV, Jimenez PC, Pessoa C, 
Amaral de Moraes ME, Odorico de Moraes M. Studies of the anticancer 
potential of plants used in Bangladeshi folk medicine. Journal of 
Ethnopharmacology. 2005; 99:21–30. 
14. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. Journal of 
Enthnopharmacology. 2005; 100:72–79.  
15. D’Arcy, W.G. & Rakotozafy, A., 1994. Solanaceae. Flore de Madagascar et 
des Comores (plantes vasculaires), famille 176. Imprimerie Officielle, 
Tananarive, Madagascar. 146 pp.  
16. Damu, A.G., Kuo, P.-C., Su, C.-R., Kuo, T.-H., Chen, T.H., Bastow, K.F., 
Lee, K.H. & Wu, T.S., 2007. Isolation, structures, and structure-cytotoxic 
activity relationships of withanolides and physalins from Physalis angulata. 
Journal of Natural Products 70(7): 1146–1152. 
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  99  JKKMMRF College of Pharmacy 
17. DGI.Kingston (2010).Department of chemistry, M/C 0212.The American 
chemical society and America society of pharmacognosy.DOI:10, PP-496-
511. 
18. Dos Santos, J.A.A., Tomassini, T.C.B, Xavier, D.C.D., Ribeiro, I.M., da 
Silva, M.T.G. & de Morais Filho, Z.B., 2003. Molluscicidal activity of 
Physalis angulata L. extracts and fractions on Biomphalaria tenagophila 
(d’Orbigny, 1835) under laboratory conditions. Memórias do Instituto 
Oswaldo Cruz 98(3): 425–428. 
19. Eyme, J., Gassita, J.N., Gbaguidi, N., Goudote, E., Guinko, S., Houngnon, P., 
Lo, I., Keita, A., Kiniffo, H.V., Kone-Bamba, D., Musampa Nseyya, A., 
Saadou,  
20. Fouche G, Cragg GM, Pillay P, Kolesnikova N, Maharaj VJ, Senabe J. In 
vitro anticancer screening of South African plants. Journal of 
Ethnopharmacology. 2008; 119:455–461.  
21. Freiburghaus F, Kaminsky R, Nkunya MHH, Brun R. Evaluation of African 
plants for their in vitrotrypanocidal activity. Journal of Ethno 
pharmacology. 1996; 55:1–11. 
22. Gamble J.S., 1979.The flora of presidency of madras. Botanical Survey of 
India,   Calcutta, India, 1935, Vol. 1-3. 
23. Harborne.J.B, 2005.Phytochemical methods, Chapman and hall London 
(3):49-52  
24. Jarvis, C., 2007. Order out of chaos: Linnean plant names and their types. 
Linnean Society of London, London, United Kingdom. 1016 pp.  
25. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA: A Cancer 
Journal for Clinicians. 2010; 60:277–300. 
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  100  JKKMMRF College of Pharmacy 
26. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nature 
Reviews: Cancer. 2004; 4:253–266. 
27. Khandelwal K.R, 2008, Practical Pharmacognosy, Pragati books Pvt Ltd: 
137-138. 
28. Kokate C.K, Purohit, A.P, and Gokhale, 2007.Nirali prakashan, Practical 
Pharmacognosy: 112-117. 
29. Kritikar KR, Basu BD. Indian Medical Plants. International book distributors 
Dehradun, India; 1995, Vol.1:641-643.  
30. Martínez M. 1993. The correct application of Physalis pruinosa L. 
(Solanaceae). Taxon 42: 103–104. 
31. Menzel M Y. 1951. The cytotaxonomy and genetics of Physalis. Proceedings 
of American Philosophical Society 95: 132–183. 
32. Nadkarni KM, Nadkarni A. Indian Materia Medica. Popular prakashan, 
Bombay; 1982, Vol.1:457-459 
33. Ochwang’I DO, Kimwele CN, Oduma JA, Gathumbi PK, Mbaria JM, Kiama 
SG. Medicinal plants used in treatment and management of cancer in 
Kakamega County Kenya. Journal of Ethnopharmacology. 2014; 151:1040–
1055.  
34. Pezzuto JM. Plant-Derived Anticancer Agents. Biochemical 
Pharmacology. 1997; 53:121–133. 
35. Phillip son JD. Medicinal Plants. Journal of Biological Education (Society of 
Biology) 1999; 31(2):109 
36. Rama murthy, D.Maria Rajesweri, et.al.(2013) alkaloids, flavonoids, tannins, 
steroids, carbohydrates, fixed oiland fats, saponin, protein. In this procedure 
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  101  JKKMMRF College of Pharmacy 
antibacterial assay and phytochemical assay are conducted. International 
Journal Of Pure and Applied Zoology Volume 1, Issue 2, June 2013. 
37. Risinger AL, Giles FJ, Mooberry SL. Microtubule dynamics as a target in 
oncology. Cancer Treatment Reviews. 2009; 35:255–261.  
38. Santhya rani, prof. RAO. S.Pippalla et. al. reported the presence of di and tri 
terpenes, saponin, flavonoids and other phenolic compounds pg. JPRHC, 
July 2009, Vol.1, No.1, 97-112.  
39. Slamet Sutanti Budi Rahayu, 2001. Physalis L. In: van Valkenburg, J.L.C.H. 
& Bunyapraphatsara, N. (Editors). Plant Resources of South-East Asia No 
12(2): Medicinal and poisonous plants 2. Backhuys Publishers, Leiden, 
Netherlands. pp. 423–426.  
40. Sodogandji, T., De Souza, S., Tchabi, A., Zinsou Dossa, C. & Zohoun, T., 
1989. Contribution aux études ethnobotaniques et floristiques en République 
Populaire du Bénin. Agence de Coopération Culturelle et Technique, Paris, 
France. 895 pp.  
41. Solowey E, Lichtenstein M, Sallo S, Paavilainen H, Solowet E, Lorberboum-
Galski H. Evaluating Medicinal Plants for Anticancer Activity. The 
Scientific World Journal. 2014; 2014:1–12 
42. Tabuti, J.R.S., 2007. Status of non-cultivated food plants in Bulamogi 
County, Uganda. African Journal of Ecology 45(s1): 96–101. 
43. Unnati S, Ripal S, Sanjeev A, Niyati A. Novel anticancer agents from plant 
sources. Chinese Journal of Natural Medicines. 2013; 11(1):0016–0023. 
44. Whitson, M. & Manos, P.S., 2005. Untangling Physalis (Solanaceae) from 
the Physaloids: a two-gene phylogeny of Physalinae. Systematic Botany 30: 
216–230 
 Chapter  11  References 
 
Dept. of Pharmaceutical Chemistry  102  JKKMMRF College of Pharmacy 
45. Whitson, M. & Manos, P.S., 2005. Untangling Physalis (Solanaceae) from 
the Physaloids: a two-gene phylogeny of Physalinae. Systematic Botany 30: 
216–230. 
46. Williams DA, Lemke TL (2002).Natural products.Foye’s principles of 
medicinal chemistry. Philadelphia: Lippincott Williams’s wilkins.p.25, ISBN 
0-683-30737. 
